JP2015101545A - Emulsion aerosol composition - Google Patents
Emulsion aerosol composition Download PDFInfo
- Publication number
- JP2015101545A JP2015101545A JP2013240852A JP2013240852A JP2015101545A JP 2015101545 A JP2015101545 A JP 2015101545A JP 2013240852 A JP2013240852 A JP 2013240852A JP 2013240852 A JP2013240852 A JP 2013240852A JP 2015101545 A JP2015101545 A JP 2015101545A
- Authority
- JP
- Japan
- Prior art keywords
- stock solution
- liquefied gas
- powder
- mass
- aerosol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000443 aerosol Substances 0.000 title claims abstract description 118
- 239000000203 mixture Substances 0.000 title claims abstract description 60
- 239000000839 emulsion Substances 0.000 title abstract description 5
- 239000000843 powder Substances 0.000 claims abstract description 106
- 239000004094 surface-active agent Substances 0.000 claims abstract description 13
- 239000011550 stock solution Substances 0.000 claims description 110
- 230000005484 gravity Effects 0.000 claims description 53
- 238000004945 emulsification Methods 0.000 claims description 20
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 239000007789 gas Substances 0.000 description 86
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 41
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 38
- -1 polyethylene terephthalate Polymers 0.000 description 37
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 35
- 238000011156 evaluation Methods 0.000 description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 239000011521 glass Substances 0.000 description 23
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 20
- 239000000377 silicon dioxide Substances 0.000 description 20
- 239000000243 solution Substances 0.000 description 17
- 235000014113 dietary fatty acids Nutrition 0.000 description 16
- 239000000194 fatty acid Substances 0.000 description 16
- 229930195729 fatty acid Natural products 0.000 description 16
- 229910052782 aluminium Inorganic materials 0.000 description 15
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 15
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 15
- 239000008213 purified water Substances 0.000 description 14
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 12
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 11
- 239000011324 bead Substances 0.000 description 11
- 150000004665 fatty acids Chemical class 0.000 description 11
- 238000009472 formulation Methods 0.000 description 11
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 11
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 10
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 10
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 10
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 10
- 229960002216 methylparaben Drugs 0.000 description 10
- 239000003240 coconut oil Substances 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 8
- 229960003237 betaine Drugs 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 7
- 239000006260 foam Substances 0.000 description 7
- 239000003205 fragrance Substances 0.000 description 7
- 229920003169 water-soluble polymer Polymers 0.000 description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 4
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- QQONPFPTGQHPMA-UHFFFAOYSA-N Propene Chemical group CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 229940071160 cocoate Drugs 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000001804 emulsifying effect Effects 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 229920002674 hyaluronan Polymers 0.000 description 4
- 229960003160 hyaluronic acid Drugs 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 150000002430 hydrocarbons Chemical class 0.000 description 4
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 4
- 239000003002 pH adjusting agent Substances 0.000 description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 description 4
- 239000005020 polyethylene terephthalate Substances 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 229940073490 sodium glutamate Drugs 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000002826 coolant Substances 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 229940105990 diglycerin Drugs 0.000 description 3
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 3
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 229960002989 glutamic acid Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229960001679 octinoxate Drugs 0.000 description 3
- 239000005871 repellent Substances 0.000 description 3
- 230000002940 repellent Effects 0.000 description 3
- 239000012508 resin bead Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- CDOOAUSHHFGWSA-OWOJBTEDSA-N (e)-1,3,3,3-tetrafluoroprop-1-ene Chemical compound F\C=C\C(F)(F)F CDOOAUSHHFGWSA-OWOJBTEDSA-N 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- AVBJHQDHVYGQLS-UHFFFAOYSA-N 2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)NC(C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 2
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 229910002012 Aerosil® Inorganic materials 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 229940069521 aloe extract Drugs 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 2
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 2
- 229940043276 diisopropanolamine Drugs 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- MVLVMROFTAUDAG-UHFFFAOYSA-N ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC MVLVMROFTAUDAG-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- SAMYCKUDTNLASP-UHFFFAOYSA-N hexane-2,2-diol Chemical compound CCCCC(C)(O)O SAMYCKUDTNLASP-UHFFFAOYSA-N 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 239000001282 iso-butane Substances 0.000 description 2
- QWTDNUCVQCZILF-UHFFFAOYSA-N isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229960001047 methyl salicylate Drugs 0.000 description 2
- 229960003632 minoxidil Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000013919 monopotassium glutamate Nutrition 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- IJDNQMDRQITEOD-UHFFFAOYSA-N sec-butylidene Natural products CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 229920003002 synthetic resin Polymers 0.000 description 2
- 239000000057 synthetic resin Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- AFNXATANNDIXLG-SFHVURJKSA-N 1-[(2r)-2-[(4-chlorophenyl)methylsulfanyl]-2-(2,4-dichlorophenyl)ethyl]imidazole Chemical compound C1=CC(Cl)=CC=C1CS[C@H](C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 AFNXATANNDIXLG-SFHVURJKSA-N 0.000 description 1
- OCAPBUJLXMYKEJ-UHFFFAOYSA-N 1-[biphenyl-4-yl(phenyl)methyl]imidazole Chemical compound C1=NC=CN1C(C=1C=CC(=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 OCAPBUJLXMYKEJ-UHFFFAOYSA-N 0.000 description 1
- UYZQWKKNVBJVOF-UHFFFAOYSA-N 1-decoxytetradecane Chemical compound CCCCCCCCCCCCCCOCCCCCCCCCC UYZQWKKNVBJVOF-UHFFFAOYSA-N 0.000 description 1
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- LQXBZWFNAKZUNM-UHFFFAOYSA-N 16-methyl-1-(16-methylheptadecoxy)heptadecane Chemical compound CC(C)CCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC(C)C LQXBZWFNAKZUNM-UHFFFAOYSA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- AZLWQVJVINEILY-UHFFFAOYSA-N 2-(2-dodecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCOCCOCCO AZLWQVJVINEILY-UHFFFAOYSA-N 0.000 description 1
- BKUWWVKLLKXDJK-UHFFFAOYSA-N 2-(dimethylamino)icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCC(N(C)C)C(O)=O BKUWWVKLLKXDJK-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- WQPYHHPVZGFKQH-UHFFFAOYSA-N 2-[1-(2-ethylphenyl)heptylidene]-1,3-dimethoxyimidazolidine-4,5-dione;propanoic acid Chemical compound CCC(O)=O.C=1C=CC=C(CC)C=1C(CCCCCC)=C1N(OC)C(=O)C(=O)N1OC WQPYHHPVZGFKQH-UHFFFAOYSA-N 0.000 description 1
- HVYJSOSGTDINLW-UHFFFAOYSA-N 2-[dimethyl(octadecyl)azaniumyl]acetate Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CC([O-])=O HVYJSOSGTDINLW-UHFFFAOYSA-N 0.000 description 1
- SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
- WITKSCOBOCOGSC-UHFFFAOYSA-N 2-dodecanoyloxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCCCC WITKSCOBOCOGSC-UHFFFAOYSA-N 0.000 description 1
- BKUKXOMYGPYFJJ-UHFFFAOYSA-N 2-ethylsulfanyl-1h-benzimidazole;hydrobromide Chemical compound Br.C1=CC=C2NC(SCC)=NC2=C1 BKUKXOMYGPYFJJ-UHFFFAOYSA-N 0.000 description 1
- ZVTDEEBSWIQAFJ-KHPPLWFESA-N 2-hydroxypropyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C)O ZVTDEEBSWIQAFJ-KHPPLWFESA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- ZSNLEVJATWJBLU-UHFFFAOYSA-N 2-tert-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(C(C)(C)C)(OC)C(=O)C1=CC=CC=C1 ZSNLEVJATWJBLU-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- UNWFFCPRJXMCNV-UHFFFAOYSA-N 3-[dodecanoyl(methyl)amino]propanoic acid Chemical compound CCCCCCCCCCCC(=O)N(C)CCC(O)=O UNWFFCPRJXMCNV-UHFFFAOYSA-N 0.000 description 1
- DDGPBVIAYDDWDH-UHFFFAOYSA-N 3-[dodecyl(dimethyl)azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC(O)CS([O-])(=O)=O DDGPBVIAYDDWDH-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 238000004438 BET method Methods 0.000 description 1
- AFWTZXXDGQBIKW-UHFFFAOYSA-N C14 surfactin Natural products CCCCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 AFWTZXXDGQBIKW-UHFFFAOYSA-N 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 239000006000 Garlic extract Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- 108010020056 Hydrogenase Proteins 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 241001072282 Limnanthes Species 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- MMOXZBCLCQITDF-UHFFFAOYSA-N N,N-diethyl-m-toluamide Chemical compound CCN(CC)C(=O)C1=CC=CC(C)=C1 MMOXZBCLCQITDF-UHFFFAOYSA-N 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- ATFFFUXLAJBBDE-FQEVSTJZSA-N N-Stearoyl glutamic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O ATFFFUXLAJBBDE-FQEVSTJZSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- PPWHTZKZQNXVAE-UHFFFAOYSA-N Tetracaine hydrochloride Chemical compound Cl.CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 PPWHTZKZQNXVAE-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 239000004110 Zinc silicate Substances 0.000 description 1
- XJXFLRWMYHIIKV-CLFAGFIQSA-N [2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-[(z)-octadec-9-enoyl]oxypropoxy]propoxy]propoxy]propoxy]propoxy]propoxy]propoxy]propoxy]propoxy]propyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COC(=O)CCCCCCC\C=C/CCCCCCCC XJXFLRWMYHIIKV-CLFAGFIQSA-N 0.000 description 1
- GORMSINSWZJIKL-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-dimethylpropyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(C)(C)COC(=O)C(CC)CCCC GORMSINSWZJIKL-UHFFFAOYSA-N 0.000 description 1
- NPTLAYTZMHJJDP-KTKRTIGZSA-N [3-[3-[3-[3-[3-[3-[3-[3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)CO NPTLAYTZMHJJDP-KTKRTIGZSA-N 0.000 description 1
- NEOSCXSMCDEQPS-UHFFFAOYSA-N [4-(2,2-dimethylpropanoyloxymethyl)-2-ethylhexyl] 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCC(CC)CC(CC)COC(=O)C(C)(C)C NEOSCXSMCDEQPS-UHFFFAOYSA-N 0.000 description 1
- ABKPAQVSXGDAOP-UHFFFAOYSA-N [5-(2,2-dimethylpropanoyloxy)-3-methylpentyl] 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCCC(C)CCOC(=O)C(C)(C)C ABKPAQVSXGDAOP-UHFFFAOYSA-N 0.000 description 1
- RKFMOTBTFHXWCM-UHFFFAOYSA-M [AlH2]O Chemical compound [AlH2]O RKFMOTBTFHXWCM-UHFFFAOYSA-M 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- YFCGDEUVHLPRCZ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-dimethyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C YFCGDEUVHLPRCZ-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- CIWBQSYVNNPZIQ-XYWKZLDCSA-N betamethasone dipropionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CIWBQSYVNNPZIQ-XYWKZLDCSA-N 0.000 description 1
- 229960002206 bifonazole Drugs 0.000 description 1
- QRZAKQDHEVVFRX-UHFFFAOYSA-N biphenyl-4-ylacetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=C1 QRZAKQDHEVVFRX-UHFFFAOYSA-N 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- SWQUTKGVXGTROS-UHFFFAOYSA-N bis(2-ethoxyethyl) butanedioate Chemical compound CCOCCOC(=O)CCC(=O)OCCOCC SWQUTKGVXGTROS-UHFFFAOYSA-N 0.000 description 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- ABJKWBDEJIDSJZ-UHFFFAOYSA-N butenafine Chemical compound C=1C=CC2=CC=CC=C2C=1CN(C)CC1=CC=C(C(C)(C)C)C=C1 ABJKWBDEJIDSJZ-UHFFFAOYSA-N 0.000 description 1
- 229960002962 butenafine Drugs 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- RZMKWKZIJJNSLQ-UHFFFAOYSA-M carpronium chloride Chemical compound [Cl-].COC(=O)CCC[N+](C)(C)C RZMKWKZIJJNSLQ-UHFFFAOYSA-M 0.000 description 1
- 229950003631 carpronium chloride Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229920003174 cellulose-based polymer Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- DNTGGZPQPQTDQF-XBXARRHUSA-N crotamiton Chemical compound C/C=C/C(=O)N(CC)C1=CC=CC=C1C DNTGGZPQPQTDQF-XBXARRHUSA-N 0.000 description 1
- 229960003338 crotamiton Drugs 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 229940119676 diethoxyethyl succinate Drugs 0.000 description 1
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 1
- AFABGHUZZDYHJO-UHFFFAOYSA-N dimethyl butane Natural products CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- JOLYVEWZEPKDIJ-UTLKBRERSA-L dipotassium;(2s)-2-(dodecanoylamino)pentanedioate Chemical compound [K+].[K+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O JOLYVEWZEPKDIJ-UTLKBRERSA-L 0.000 description 1
- WDRWZVWLVBXVOI-QTNFYWBSSA-L dipotassium;(2s)-2-aminopentanedioate Chemical compound [K+].[K+].[O-]C(=O)[C@@H](N)CCC([O-])=O WDRWZVWLVBXVOI-QTNFYWBSSA-L 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- HWUINYGRRJTXGE-UTLKBRERSA-L disodium;(2s)-2-(dodecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O HWUINYGRRJTXGE-UTLKBRERSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229950010030 dl-alanine Drugs 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960003913 econazole Drugs 0.000 description 1
- OYFJQPXVCSSHAI-QFPUQLAESA-N enalapril maleate Chemical compound OC(=O)\C=C/C(O)=O.C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 OYFJQPXVCSSHAI-QFPUQLAESA-N 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 229960000655 ensulizole Drugs 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 1
- 229960000192 felbinac Drugs 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000020706 garlic extract Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 229940049906 glutamate Drugs 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229940014041 hyaluronate Drugs 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 229960004393 lidocaine hydrochloride Drugs 0.000 description 1
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- ZADYMNAVLSWLEQ-UHFFFAOYSA-N magnesium;oxygen(2-);silicon(4+) Chemical compound [O-2].[O-2].[O-2].[Mg+2].[Si+4] ZADYMNAVLSWLEQ-UHFFFAOYSA-N 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- PVWXTVUZGJXFJQ-UHFFFAOYSA-N methyl 4-methyl-3-phenyl-2-propan-2-ylpent-2-enoate Chemical compound COC(=O)C(C(C)C)=C(C(C)C)C1=CC=CC=C1 PVWXTVUZGJXFJQ-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960002509 miconazole Drugs 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- LVALCNRQGAWRFC-UHFFFAOYSA-N n,n,2-trimethylbenzamide Chemical compound CN(C)C(=O)C1=CC=CC=C1C LVALCNRQGAWRFC-UHFFFAOYSA-N 0.000 description 1
- FHJRFIYKPIXQNQ-UHFFFAOYSA-N n,n-diethyloctanamide Chemical compound CCCCCCCC(=O)N(CC)CC FHJRFIYKPIXQNQ-UHFFFAOYSA-N 0.000 description 1
- YWFWDNVOPHGWMX-UHFFFAOYSA-N n,n-dimethyldodecan-1-amine Chemical compound CCCCCCCCCCCCN(C)C YWFWDNVOPHGWMX-UHFFFAOYSA-N 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- HLERILKGMXJNBU-UHFFFAOYSA-N norvaline betaine Chemical compound CCCC(C([O-])=O)[N+](C)(C)C HLERILKGMXJNBU-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- WZLSDESGWZJKEG-UHFFFAOYSA-N octan-3-yl 2-(dimethylamino)benzoate Chemical compound CCCCCC(CC)OC(=O)C1=CC=CC=C1N(C)C WZLSDESGWZJKEG-UHFFFAOYSA-N 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229960003483 oxiconazole Drugs 0.000 description 1
- QRJJEGAJXVEBNE-MOHJPFBDSA-N oxiconazole Chemical compound ClC1=CC(Cl)=CC=C1CO\N=C(C=1C(=CC(Cl)=CC=1)Cl)\CN1C=NC=C1 QRJJEGAJXVEBNE-MOHJPFBDSA-N 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229940099874 potassium lauroyl glutamate Drugs 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 239000011164 primary particle Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940045944 sodium lauroyl glutamate Drugs 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 229960002607 sulconazole Drugs 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- NJGWOFRZMQRKHT-UHFFFAOYSA-N surfactin Natural products CC(C)CCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-UHFFFAOYSA-N 0.000 description 1
- NJGWOFRZMQRKHT-WGVNQGGSSA-N surfactin C Chemical compound CC(C)CCCCCCCCC[C@@H]1CC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-WGVNQGGSSA-N 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229960002494 tetracaine hydrochloride Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 239000005028 tinplate Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 235000019352 zinc silicate Nutrition 0.000 description 1
- XSMMCTCMFDWXIX-UHFFFAOYSA-N zinc silicate Chemical compound [Zn+2].[O-][Si]([O-])=O XSMMCTCMFDWXIX-UHFFFAOYSA-N 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、乳化型エアゾール組成物に関する。さらに詳しくは、水性原液および液化ガスからなる乳化型エアゾール組成物であって、製造時の水性原液と液化ガスとの乳化が容易であり、長期間静置されてもパウダーのケーキングが起こりにくく再乳化しやすい乳化型エアゾール組成物に関する。 The present invention relates to an emulsified aerosol composition. More specifically, it is an emulsified aerosol composition composed of an aqueous stock solution and a liquefied gas, which can easily emulsify an aqueous stock solution and a liquefied gas at the time of manufacture, and does not easily cause powder caking even if left standing for a long time. The present invention relates to an emulsified aerosol composition that is easily emulsified.
従来から乳化型エアゾール組成物における乳化のしやすさ、乳化安定性、再乳化性などを向上させることを目的として、種々のパウダーを乳化補助剤として含有するエアゾール組成物が検討されている。 Conventionally, an aerosol composition containing various powders as an emulsification aid has been studied for the purpose of improving ease of emulsification, emulsification stability, re-emulsification, and the like in an emulsified aerosol composition.
例えば、特許文献1には、特定の平均一次粒子径を有するパウダーと液化ガスとを特定の重量比で含有するエアゾール組成物が記載されている。特許文献2には、比表面積の異なる2種のパウダーを含有する乳化型エアゾール組成物が記載されている。また、特許文献3には球状粉体を用いることで充填状態の均一性が促進され、吐出時の均一性が向上され、さらに、球状粉体を中空の球状粉体とすることでガスの気散を抑制できることが記載されている。 For example, Patent Document 1 describes an aerosol composition containing a powder having a specific average primary particle size and a liquefied gas in a specific weight ratio. Patent Document 2 describes an emulsified aerosol composition containing two types of powders having different specific surface areas. Further, in Patent Document 3, the use of spherical powder promotes the uniformity of the filling state, improves the uniformity during discharge, and further, the spherical powder is made into a hollow spherical powder to improve the gas gas. It is described that dispersion can be suppressed.
しかしながら、特許文献1および2のエアゾール組成物が含有するパウダーは真比重が大きいパウダーであるため、長期間静置した場合にパウダーが沈降して容器の底部で固まり(ケーキング)、使用するためにはパウダーを再分散させるために激しく振とうする必要があるという問題や、分散しきれずに固まったパウダーがエアゾールバルブなどの通路の途中で詰まり噴射出来なくなるという問題がある。また、特許文献3には真比重についての記載はなく、ケーキングを抑制することについては考慮されていない。 However, since the powders contained in the aerosol compositions of Patent Documents 1 and 2 are powders having a large true specific gravity, the powders settle and solidify (caking) at the bottom of the container when used for a long period of time. However, there is a problem that it is necessary to shake vigorously in order to re-disperse the powder, and a problem that the powder that cannot be dispersed completely becomes clogged in the middle of a passage such as an aerosol valve and cannot be injected. Patent Document 3 does not describe true specific gravity, and does not consider suppressing caking.
また、パウダーを含有するエアゾール組成物をポリエチレンテレフタレートなどの透明な合成樹脂製のエアゾール容器に充填した場合は、底部に沈降したパウダーが目立ちやすく、特に、エアゾール容器の耐圧強度を確保するために底部をペタロイド構造にした場合は、底部の凹部にパウダーが固く凝集し、攪拌球を入れても再乳化しにくいという問題がある。 In addition, when an aerosol composition containing powder is filled in an aerosol container made of a transparent synthetic resin such as polyethylene terephthalate, the powder settled on the bottom is easily noticeable, especially in order to ensure the pressure resistance of the aerosol container. In the case of using a petaloid structure, there is a problem that the powder aggregates tightly in the concave portion at the bottom, and it is difficult to re-emulsify even if a stirring ball is inserted.
本発明は上記問題に鑑みてなされたものであり、製造時の水性原液と液化ガスとの乳化が容易であって取り扱いが容易であり、さらに長期間静置されてもパウダーのケーキングが起こりにくく再乳化しやすい乳化型エアゾール組成物を提供することを目的とする。 The present invention has been made in view of the above problems, and it is easy to emulsify an aqueous stock solution and a liquefied gas at the time of production, and is easy to handle. An object of the present invention is to provide an emulsified aerosol composition that can be easily re-emulsified.
本発明は、界面活性剤およびパウダーを含有する水性原液ならびに液化ガスを含有し、水性原液と液化ガスとが乳化する乳化型エアゾール組成物であって、前記パウダーが、水性原液と液化ガスとが分離している状態では、水性原液と液化ガスとの間に存在する乳化型エアゾール組成物に関する。 The present invention is an emulsified aerosol composition comprising an aqueous stock solution containing a surfactant and a powder and a liquefied gas, wherein the aqueous stock solution and the liquefied gas are emulsified, wherein the powder comprises an aqueous stock solution and a liquefied gas. In the separated state, the present invention relates to an emulsified aerosol composition that exists between an aqueous stock solution and a liquefied gas.
前記パウダーの真比重が0.10〜0.80g/mlであることが好ましい。 It is preferable that the true specific gravity of the powder is 0.10 to 0.80 g / ml.
前記パウダーが親水性であり、真比重が前記液化ガスの比重よりも小さいことが好ましい。 It is preferable that the powder is hydrophilic and the true specific gravity is smaller than the specific gravity of the liquefied gas.
前記パウダーが中空構造であることが好ましい。 It is preferable that the powder has a hollow structure.
前記パウダーの比表面積が0.1〜70m2/gであることが好ましい。 It is preferable that the powder has a specific surface area of 0.1 to 70 m 2 / g.
前記水性原液を10〜60質量%、前記液化ガスを40〜90質量%含有することが好ましい。 It is preferable to contain 10-60 mass% of the aqueous stock solution and 40-90 mass% of the liquefied gas.
本発明によれば、パウダーを水性原液中に含有し、水性原液と液化ガスとが分離している状態ではパウダーを水性原液と液化ガスとの間に存在させることにより、水性原液と液化ガスとの乳化が容易となり製造しやすく、長期間静置してもケーキングが起こりにくく再乳化しやすい乳化型エアゾール組成物を提供することができる。 According to the present invention, the powder is contained in the aqueous stock solution, and in the state where the aqueous stock solution and the liquefied gas are separated, the powder is present between the aqueous stock solution and the liquefied gas, whereby the aqueous stock solution and the liquefied gas are Thus, it is possible to provide an emulsified aerosol composition that is easy to emulsify and easy to produce, and is less susceptible to caking even after standing for a long period of time and is easily re-emulsified.
本発明の乳化型エアゾール組成物は、界面活性剤およびパウダーを含有する水性原液ならびに液化ガスを含有する乳化型エアゾール組成物である。 The emulsified aerosol composition of the present invention is an emulsified aerosol composition containing an aqueous stock solution containing a surfactant and powder and a liquefied gas.
前記界面活性剤は、パウダーを分散させて水性原液と液化ガスとを乳化させる目的で用いられる。 The surfactant is used for the purpose of emulsifying the aqueous stock solution and the liquefied gas by dispersing the powder.
前記界面活性剤としては、たとえば、POEモノラウレート、POEモノステアレート、POEモノオレエートなどのポリオキシエチレン脂肪酸エステル、PEG−20ソルビタンココエート、POEソルビタンモノラウレート、POEソルビタンモノステアレート、POEソルビタンモノオレエートなどのポリオキシエチレンソルビタン脂肪酸エステル、POEグリセリルモノステアレート、POEグリセリルモノオレエートなどのポリオキシエチレングリセリン脂肪酸エステル、POEソルビットモノラウレート、POEソルビットテトラステアレート、POEソルビットテトラオレエートなどのポリオキシエチレンソルビット脂肪酸エステル、POEセチルエーテル、POEステアリルエーテル、POEオレイルエーテル、POEラウリルエーテル、POEベヘニルエーテル、POEオクチルドデシルエーテル、POEイソセチルエーテル、POEイソステアリルエーテルなどのポリオキシエチレンアルキルエーテル、POE・POPセチルエーテル、POE・POPデシルテトラデシルエーテルなどのポリオキシエチレンポリオキシプロピレンアルキルエーテル、デカグリセリルモノラウレート、デカグリセリルモノミリステート、デカグリセリルモノステアレート、デカグリセリルモノオレエート、デカグリセリルジオレエート、ヘキサグリセリルモノラウレート、ヘキサグリセリルモノステアレート、ヘキサグリセリルモノオレエートなどのポリグリセリン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油などの非イオン性界面活性剤、ポリオキシエチレン・メチルポリシロキサン共重合体、ポリオキシプロピレン・メチルポリシロキサン共重合体、ポリ(オキシエチレン・オキシプロピレン)・メチルポリシロキサン共重合体などのシリコーン系界面活性剤、サーファクチンナトリウム、シクロデキストリン、水添酵素大豆レシチンなどの天然系界面活性剤、
などがあげられる。
Examples of the surfactant include polyoxyethylene fatty acid esters such as POE monolaurate, POE monostearate, and POE monooleate, PEG-20 sorbitan cocoate, POE sorbitan monolaurate, POE sorbitan monostearate, and POE sorbitan monooleate. Polyoxyethylene sorbitan fatty acid ester such as POE, polyoxyethylene glyceryl fatty acid ester such as POE glyceryl monostearate, POE glyceryl monooleate, poly such as POE sorbite monolaurate, POE sorbite tetrastearate, POE sorbite tetraoleate Oxyethylene sorbite fatty acid ester, POE cetyl ether, POE stearyl ether, POE oleyl ether, POE laur Polyether, POE behenyl ether, POE octyldodecyl ether, POE isocetyl ether, POE isostearyl ether, and other polyoxyethylene alkyl ethers, POE / POP cetyl ether, POE / POP decyl tetradecyl ether, and other polyoxyethylene polyoxypropylene alkyls Ether, decaglyceryl monolaurate, decaglyceryl monomyristate, decaglyceryl monostearate, decaglyceryl monooleate, decaglyceryl dioleate, hexaglyceryl monolaurate, hexaglyceryl monostearate, hexaglyceryl monooleate, etc. Non-ionic surfactants such as polyglycerin fatty acid ester, polyoxyethylene hydrogenated castor oil, polyoxyethylene methyl Silicone surfactants such as resiloxane copolymer, polyoxypropylene / methylpolysiloxane copolymer, poly (oxyethylene / oxypropylene) / methylpolysiloxane copolymer, surfactin sodium, cyclodextrin, hydrogenase Natural surfactants such as soy lecithin,
Etc.
前記界面活性剤の含有量は、水性原液中0.1〜15質量%であることが好ましく、さらには0.3〜10質量%であることが好ましい。前記界面活性剤の含有量が0.1質量%よりも少ない場合は水性原液と液化ガスとが乳化しにくくなる傾向があり、15質量%よりも多い場合は界面活性剤が皮膚上に残りやすく、べたつくなど使用感が悪くなる傾向がある。 The content of the surfactant is preferably 0.1 to 15% by mass, more preferably 0.3 to 10% by mass in the aqueous stock solution. When the content of the surfactant is less than 0.1% by mass, the aqueous stock solution and the liquefied gas tend to be difficult to emulsify, and when the content is more than 15% by mass, the surfactant tends to remain on the skin. There is a tendency for the feeling of use to become worse, such as stickiness.
前記パウダーは、製造時にエアゾール容器内で水性原液と液化ガスとを乳化しやすくする(初期乳化)、長期間静置されて水性原液と液化ガスとが分離しても、消費者が使用する前に簡単に振るだけで乳化する(再乳化)、吐出物中に液化ガスを長く保持させて氷結しやすくする、パチパチと泡が弾ける感触や音を強くするなど、吐出物の性能を高くするなどの目的で用いられる。 The powder makes it easy to emulsify the aqueous stock solution and the liquefied gas in the aerosol container at the time of manufacture (initial emulsification). Even if the aqueous stock solution and the liquefied gas are separated after being left for a long time, before the consumer uses Easily emulsify by simply shaking (re-emulsification), keep the liquefied gas in the discharge for a long time, make it easy to freeze, enhance the feel and sound of crackling and foaming, etc. It is used for the purpose.
また、前記パウダーとして水性原液と液化ガスとが分離している状態では、水性原液と液化ガスとの間に存在するパウダーを用いることにより、エアゾール容器に充填された状態で長期間静置されて水性原液と液化ガスとが分離した場合であっても、容器の底部に沈降しない、つまりケーキングが起こりにくく再乳化しやすい乳化型エアゾール組成物とすることができる。 Further, in the state where the aqueous stock solution and the liquefied gas are separated as the powder, by using the powder existing between the aqueous stock solution and the liquefied gas, the powder can be left standing for a long time in a state filled in an aerosol container. Even when the aqueous stock solution and the liquefied gas are separated, an emulsified aerosol composition that does not settle at the bottom of the container, that is, does not easily cause caking and can be easily re-emulsified.
さらに、本発明の乳化型エアゾール組成物においては、前記パウダーとして表面が親水性であるパウダーを用いることにより、水性原液中に分散しやすく、液化ガスを充填するときの攪拌作用で乳化し始め、その後の水性原液と液化ガスとを乳化させる振とう工程を簡略化でき、乳化後エアゾール製品が倉庫などで長期保管された後でも再乳化しやすい乳化型エアゾール組成物とすることができる。 Furthermore, in the emulsified aerosol composition of the present invention, by using a powder having a hydrophilic surface as the powder, it is easy to disperse in an aqueous stock solution and begins to emulsify with a stirring action when filled with a liquefied gas, The subsequent shaking step of emulsifying the aqueous stock solution and the liquefied gas can be simplified, and the emulsified aerosol composition can be easily re-emulsified even after the aerosol product after emulsification is stored for a long time in a warehouse or the like.
水性原液と液化ガスとが分離している状態において水性原液と液化ガスとの間に前記パウダーを存在させるためには、水性原液(パウダーを除く)および液化ガスの比重ならびにパウダーの真比重が、下記の式(1)または(2)の関係を満たすように組み合わせることが考えられる。
(1)液化ガスの比重<パウダーの真比重<水性原液(パウダーを除く)の比重
(2)水性原液(パウダーを除く)の比重<パウダーの真比重<液化ガスの比重
In order for the powder to exist between the aqueous stock solution and the liquefied gas in a state where the aqueous stock solution and the liquefied gas are separated, the specific gravity of the aqueous stock solution (excluding powder) and the liquefied gas and the true specific gravity of the powder are: It is conceivable to combine them so as to satisfy the relationship of the following formula (1) or (2).
(1) Specific gravity of liquefied gas <True specific gravity of powder <Specific gravity of aqueous concentrate (excluding powder) (2) Specific gravity of aqueous concentrate (excluding powder) <True specific gravity of powder <Specific gravity of liquefied gas
また、本発明によれば、前記の関係が、
パウダーの真比重<液化ガスの比重<水性原液(パウダーを除く)の比重
となる場合であっても、所定の真比重の範囲を満たす親水性パウダーを用いることで、水性原液と液化ガスとが分離しても、上層にある液化ガス中を浮上しようとするパウダーの浮力と、下層にある水性原液中に分散しようとするパウダー表面の親水基による親和力とのバランスにより、パウダーは液化ガスの上面に浮遊せずに水性原液と液化ガスとの界面に存在しやすくなるため、再乳化しやすい乳化型エアゾール組成物とすることができる。
Moreover, according to the present invention, the above relationship is
Even if the true specific gravity of the powder is less than the specific gravity of the liquefied gas <the specific gravity of the aqueous stock solution (excluding the powder), by using hydrophilic powder that satisfies the predetermined true specific gravity range, Even if the powder is separated, the upper surface of the liquefied gas is determined by the balance between the buoyancy of the powder that attempts to float in the liquefied gas in the upper layer and the affinity by the hydrophilic group of the powder surface that tends to disperse in the aqueous stock solution in the lower layer. Therefore, it is easy to be present at the interface between the aqueous stock solution and the liquefied gas without floating, so that an emulsified aerosol composition that can be easily re-emulsified can be obtained.
前記パウダーの真比重は0.10〜0.80g/mlが好ましく、0.15〜0.70g/mlがより好ましい。真比重が0.10g/mlより小さい場合は、水性原液や液化ガスに比べて比重が小さ過ぎるために、水性原液と液化ガスとが分離したときに液化ガスの上面に浮遊してしまい再乳化しにくくなる傾向がある。また、0.80g/mlより大きい場合はエアゾール組成物の比重によっては容器の底部に沈降してしまうためケーキングが起きやすく、再乳化しにくくなる傾向がある。 The true specific gravity of the powder is preferably 0.10 to 0.80 g / ml, and more preferably 0.15 to 0.70 g / ml. If the true specific gravity is less than 0.10 g / ml, the specific gravity is too small compared to the aqueous stock solution or liquefied gas, so when the aqueous stock solution and liquefied gas are separated, they float on the upper surface of the liquefied gas and are re-emulsified Tend to be difficult to do. On the other hand, when it is larger than 0.80 g / ml, depending on the specific gravity of the aerosol composition, it settles at the bottom of the container, so that caking tends to occur and re-emulsification tends to be difficult.
前記パウダーの比表面積は0.1〜70m2/gが好ましく、0.5〜60m2/gがより好ましい。比表面積が0.1m2/gよりも小さい場合は、接触面積が小さすぎるため、前述の効果が得られにくい傾向があり、70m2/gよりも大きい場合は、パウダーの表面に他の成分が吸着しやすく、分散性が悪化する傾向、乳化しにくくなる傾向がある。なお、本発明における比表面積は、窒素を用いたBET法により測定される比表面積とする。 The specific surface area of the powder is preferably 0.1~70m 2 / g, 0.5~60m 2 / g is more preferable. When the specific surface area is smaller than 0.1 m 2 / g, the contact area is too small, and thus the above-mentioned effect tends to be hardly obtained. When the specific surface area is larger than 70 m 2 / g, other components are added to the surface of the powder. Tends to be adsorbed, dispersibility tends to deteriorate, and emulsification tends to be difficult. In addition, let the specific surface area in this invention be a specific surface area measured by BET method using nitrogen.
前記パウダーとしては、シリカビーズ、ガラスビーズ、樹脂ビーズなどがあげられ、なかでも、前記真比重に調整しやすい点から中空構造であることが好ましく、特に親水性に優れる点から中空シリカビーズや中空ガラスビーズが好ましい。 Examples of the powder include silica beads, glass beads, and resin beads. Among these, a hollow structure is preferable from the viewpoint of easy adjustment to the true specific gravity, and hollow silica beads and hollow are particularly preferable from the viewpoint of excellent hydrophilicity. Glass beads are preferred.
前記パウダーの含有量は、水性原液中0.01〜10質量%が好ましく、0.50〜5質量%がより好ましい。前記パウダーの含有量が0.01質量%よりも少ない場合はパウダーを含有する効果が得られにくくなる傾向がある。また、10質量%よりも多い場合は含有量が多くなり過ぎケーキングしやすくなる傾向がある。 The content of the powder is preferably 0.01 to 10% by mass, and more preferably 0.50 to 5% by mass in the aqueous stock solution. When the content of the powder is less than 0.01% by mass, the effect of containing the powder tends to be difficult to obtain. On the other hand, when the amount is more than 10% by mass, the content tends to be too high and caking tends to occur.
前記水性原液には、製品の性能や目的などに応じて、有効成分、アルコール、水溶性高分子、pH調整剤、油分、その他のパウダーなどを含有することができる。 The aqueous stock solution may contain an active ingredient, alcohol, a water-soluble polymer, a pH adjuster, an oil component, and other powders depending on the performance and purpose of the product.
前記有効成分は、皮膚などに付着あるいは揮発して効果を発揮するもの、空間に放出されて効果を発揮するものであり、たとえば、l−メントール、カンフル、ミントオイルなどの清涼剤、クロタミトン、d−カンフルなどの鎮痒剤、サリチル酸メチル、インドメタシン、ピロキシカム、フェルビナク、ケトプロフェンなどの消炎鎮痛剤、オキシコナゾール、クロトリマゾール、スルコナゾール、ビフォナゾール、ミコナゾール、イソコナゾール、エコナゾール、チオコナゾール、ブテナフィン、およびこれらの塩酸塩、硝酸塩、酢酸塩などの抗真菌剤、アラントインヒドロキシアルミニウム、タンニン酸、クエン酸、乳酸などの収斂剤、アラントイン、グリチルレチン酸、グリチルリチン酸ジカリウム、アズレンなどの抗炎症剤、塩酸ジブカイン、塩酸テトラカイン、リドカイン、塩酸リドカインなどの局所麻酔剤、ジフェンヒドラミン、塩酸ジフェンヒドラミン、マレイン酸クロルフェニラミンなどの抗ヒスタミン剤、塩化カルプロニウム、トコフェロールおよび酢酸トコフェロールなどの誘導体、トウガラシチンキ、カンタリスチンキ、センブリエキス、ニンニクエキス、ニコチン酸ベンジル、ミノキシジル、ベタメタゾン−17、21−ジプロピオネート、プロスタグランジンE2などの血行促進剤、コラーゲン、キシリトール、ソルビトール、アロエ抽出液、イチョウエキス、ヒアルロン酸、ヒアルロン酸ナトリウム、乳酸ナトリウム、DL−ピロリドンカルボン酸塩、ケラチン、カゼイン、レシチン、尿素などの保湿剤、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、ジメチルアミノ安息香酸エチルヘキシル、パラアミノ安息香酸、パラアミノ安息香酸エチル、パラジメチルアミノ安息香酸2−エチルヘキスル、サリチル酸エチルヘキシル、メトキシケイ皮酸エチルヘキシル、ジイソプロピルケイ皮酸メチル、オクトクリレン、オキシベンゾン−3、オキシベンゾン−4、ジメトキシベンジリデンジオキソイミダゾリジンプロピオン酸エチルヘキシル、フェニルベンズイミダゾールスルホン酸、ポリシリコン−15、t−ブチルメトキシジベンゾイルメタン、メチレンビスベンゾトリアゾリルテトラメチルブチルフェノールなどの紫外線吸収剤、酸化チタン、酸化亜鉛などの紫外線散乱剤、パラオキシ安息香酸エステル、安息香酸ナトリウム、ソルビン酸カリウム、フェノキシエタノール、塩化ベンザルコニウム、塩化ベンゼトニウム、塩化クロルヘキシジン、感光素、パラクロルメタクレゾールなどの殺菌消毒剤、グリシン、アラニン、ロイシン、アスパラギン酸、グルタミン酸、アルギニンなどのアミノ酸、パントテン酸カルシウム、アスコルビン酸リン酸マグネシウム、アスコルビン酸ナトリウムなどのビタミン類、N,N−ジエチル−m−トルアミド(ディート)、カプリル酸ジエチルアミド、ハーブエキスなどの害虫忌避剤、緑茶エキス、柿タンニン、銀などの消臭成分、ラウリルジメチルアミノ酢酸ベタイン(ラウリルベタイン)、ステアリルベタイン、ラウリン酸アミドプロピルベタイン、ラウリルヒドロキシスルホベタイン、ステアリルジメチルアミノ酢酸ベタイン、ドデシルアミノメチルジメチルスルホプロピルベタイン、オクタデシルアミノメチルジメチルスルホプロピルベタインなどのアルキルベタイン、ヤシ酸アミドプロピルベタイン、ヤシ油脂肪酸アミドプロピルジメチルアミノ酢酸ベタイン(コカミドプロピルベタイン)、コカミドプロピルヒドロキシスルタイン、などの脂肪酸アミドプロピルベタインなどのベタイン型、2−アルキル−N−カルボキシメチル−N−ヒドロキシエチルイミダゾリニウムベタインなどのアルキルイミダゾール型;、ラウロイルグルタミン酸ナトリウム、ラウロイルグルタミン酸カリウム、ラウロイルメチル−β−アラニンなどのアミノ酸型、ラウリルジメチルアミンN−オキシド、オレイルジメチルアミンN−オキシドなどのアミンオキシド型などの両性界面活性剤、脂肪酸石鹸、アルキル硫酸塩、ポリオキシエチレンアルキルエーテル硫酸塩、アルキルリン酸塩、ポリオキシエチレンアルキルエーテルリン酸塩などのアニオン系界面活性剤、N−ヤシ油脂肪酸アシル−L−グルタミン酸トリエタノールアミン、N−ヤシ油脂肪酸アシル−L−グルタミン酸カリウム、N−ヤシ油脂肪酸アシル−L−グルタミン酸ナトリウム、N−ラウロイル−L−グルタミン酸トリエタノールアミン、N−ラウロイル−L−グルタミン酸カリウム、N−ラウロイル−L−グルタミン酸ナトリウム、N−ミリストイル−L−グルタミン酸カリウム、N−ミリストイル−L−グルタミン酸ナトリウムおよびN−ステアロイル−L−グルタミン酸ナトリウムなどのN−アシルグルタミン酸塩、N−ヤシ油脂肪酸アシル−L−グルタミン酸、N−ラウロイル−L−グルタミン酸、N−ステアロイル−L−グルタミン酸などのN−アシルグルタミン酸、N−ヤシ油脂肪酸アシルグリシンカリウム、N−ヤシ油脂肪酸アシルグリシンナトリウムなどのN−アシルグリシン塩、N−ヤシ油脂肪酸アシル−DL−アラニントリエタノールアミンなどのN−アシルアラニン塩などのアミノ酸系界面活性剤などの洗浄剤、塩化ステアリルトリメチルアンモニウム、塩化セチルトリメチルアンモニウムなどのカチオン性界面活性剤などのトリートメント剤、香料などがあげられる。 The active ingredients are those that adhere to or volatilize the skin, etc., and are effective when released into the space. For example, 1-menthol, camphor, mint oil and other refreshing agents, crotamiton, d -Antipruritics such as camphor, anti-inflammatory analgesics such as methyl salicylate, indomethacin, piroxicam, felbinac, ketoprofen, oxyconazole, clotrimazole, sulconazole, bifonazole, miconazole, isconazole, econazole, thioconazole, butenafine, and their hydrochlorides Antifungal agents such as nitrates and acetates, astringents such as allantoin hydroxyaluminum, tannic acid, citric acid and lactic acid, anti-inflammatory agents such as allantoin, glycyrrhetinic acid, dipotassium glycyrrhizinate and azulene, dibu hydrochloride Local anesthetics such as indo, tetracaine hydrochloride, lidocaine, lidocaine hydrochloride, antihistamines such as diphenhydramine, diphenhydramine hydrochloride, chlorpheniramine maleate, derivatives such as carpronium chloride, tocopherol and tocopherol acetate, red pepper tincture, cantalis tincture, assembly extract , Garlic extract, benzyl nicotinate, minoxidil, betamethasone-17, 21-dipropionate, prostaglandin E2, and other blood circulation promoters, collagen, xylitol, sorbitol, aloe extract, ginkgo biloba extract, hyaluronic acid, sodium hyaluronate, sodium lactate , Moisturizers such as DL-pyrrolidonecarboxylate, keratin, casein, lecithin, urea, diethylaminohydroxybenzoylbenzoic acid Xylyl, ethylhexyl dimethylaminobenzoate, paraaminobenzoic acid, ethyl paraaminobenzoate, 2-ethylhexyl paradimethylaminobenzoate, ethylhexyl salicylate, ethylhexyl methoxycinnamate, methyl diisopropylcinnamate, octocrylene, oxybenzone-3, oxybenzone-4 , UV absorbers such as ethyl hexyl dimethoxybenzylidenedioxoimidazolidine propionate, phenylbenzimidazole sulfonic acid, polysilicon-15, t-butylmethoxydibenzoylmethane, methylenebisbenzotriazolyltetramethylbutylphenol, titanium oxide, zinc oxide UV scattering agents such as paraoxybenzoate, sodium benzoate, potassium sorbate, phenoxyethanol, benzoyl chloride Disinfectants such as sarkonium, benzethonium chloride, chlorhexidine chloride, photosensitizers, parachlormetacresol, amino acids such as glycine, alanine, leucine, aspartic acid, glutamic acid, arginine, calcium pantothenate, magnesium phosphate ascorbate, sodium ascorbate Vitamins such as N, N-diethyl-m-toluamide (diet), pest repellents such as caprylic acid diethylamide, herbal extracts, green tea extract, strawberry tannin, deodorizing ingredients such as silver, lauryldimethylaminoacetic acid betaine (lauryl) Betaine), stearyl betaine, amidopropyl betaine laurate, lauryl hydroxysulfo betaine, stearyl dimethylaminoacetic acid betaine, dodecylaminomethyldimethylsulfopropyl betaine , Alkylbetaines such as octadecylaminomethyldimethylsulfopropylbetaine, amide propylbetaine coconut, fatty acid amidepropylbetaine such as coconut oil fatty acid amidepropyldimethylaminoacetic acid betaine (cocamidopropylbetaine), cocamidopropylhydroxysultain, etc. Betaine type, alkylimidazole type such as 2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine; amino acid type such as sodium lauroylglutamate, potassium lauroylglutamate, lauroylmethyl-β-alanine, lauryldimethylamine N -Amphoteric surfactants such as oxides, amine oxides such as oleyldimethylamine N-oxide, fatty acid soaps, alkyl sulfates, polyoxyethylenes Anionic surfactants such as polyalkyl ether sulfate, alkyl phosphate, polyoxyethylene alkyl ether phosphate, N-coconut oil fatty acid acyl-L-glutamic acid triethanolamine, N-coconut oil fatty acid acyl-L- Potassium glutamate, N-coconut oil fatty acid acyl-L-sodium glutamate, N-lauroyl-L-glutamic acid triethanolamine, N-lauroyl-L-potassium glutamate, N-lauroyl-L-sodium glutamate, N-myristoyl-L- N-acyl glutamate such as potassium glutamate, N-myristoyl-L-sodium glutamate and N-stearoyl-L-sodium glutamate, N-coconut oil fatty acid acyl-L-glutamic acid, N-lauroyl-L-glutamic acid, N N-acylglutamic acid such as stearoyl-L-glutamic acid, N-acylglycine salt such as N-coconut oil fatty acid acylglycine potassium, N-coconut oil fatty acid acylglycine sodium, N-coconut oil fatty acid acyl-DL-alanine triethanolamine And detergents such as N-acylalanine salts such as N-acylalanine salts, treatment agents such as cationic surfactants such as stearyltrimethylammonium chloride and cetyltrimethylammonium chloride, and fragrances.
前記有効成分を含有する場合の含有量は、水性原液中0.01〜30質量%であることが好ましく、さらには0.10〜25質量%であることが好ましい。前記有効成分の含有量が0.01質量%よりも少ない場合は有効成分の効果が得られにくく、30質量%よりも多い場合は乳化を阻害する場合がある。 When the active ingredient is contained, the content in the aqueous stock solution is preferably 0.01 to 30% by mass, and more preferably 0.10 to 25% by mass. When the content of the active ingredient is less than 0.01% by mass, it is difficult to obtain the effect of the active ingredient, and when it is more than 30% by mass, emulsification may be inhibited.
前記アルコールは水に溶解しない有効成分の溶媒、吐出物の状態を調整するなどの目的で用いられ、たとえば、エタノール、イソプロパノールなどの炭素数が2〜3個の1価アルコール、エチレングリコール、プロピレングリコール、1,3−ブチレングリコール、ジエチレングリコール、ジプロピレングリコール、グリセリン、ジグリセリンなどの2〜3価のポリオールなどがあげられる。 The alcohol is an active ingredient solvent that does not dissolve in water, and is used for the purpose of adjusting the state of the discharged product, for example, monohydric alcohols having 2 to 3 carbon atoms such as ethanol, isopropanol, ethylene glycol, propylene glycol, etc. 1,3-butylene glycol, diethylene glycol, dipropylene glycol, glycerin, diglycerin and other divalent polyols.
前記アルコールを含有する場合の含有量は、水性原液中0.1〜40質量%であることが好ましく、さらには0.3〜30質量%であることが好ましい。前記アルコールの含有量が0.1質量%よりも少ない場合はアルコールの効果が得られにくく、40質量%よりも多い場合は乳化しにくくなる傾向がある。 When the alcohol is contained, the content in the aqueous stock solution is preferably 0.1 to 40% by mass, more preferably 0.3 to 30% by mass. When the content of the alcohol is less than 0.1% by mass, the effect of the alcohol is hardly obtained, and when the content is more than 40% by mass, the emulsification tends to be difficult.
前記水溶性高分子は水性原液の粘性を高くし、パウダーを長く分散させる、吐出物中に液化ガスを長く保持させて水性原液を氷結しやすくする、パチパチと弾ける感触や音を強くするなどの目的で用いられる。 The water-soluble polymer increases the viscosity of the aqueous stock solution, disperses the powder for a long time, keeps the liquefied gas in the discharged material longer, makes it easier to freeze the aqueous stock solution, makes the crackling feel and sound stronger, etc. Used for purposes.
前記水溶性高分子としては、たとえば、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、カルボキシメチルセルロースナトリウムなどのセルロース系高分子、キサンタンガム、カラギーナン、アラビアゴム、トラガントゴム、カチオン化グアガム、グアガム、ジェランガム、ローカストビーンガムなどのガム質、デキストラン、カルボキシメチルデキストランナトリウム、デキストリン、ゼラチン、ペクチン、デンプン、トウモロコシデンプン、コムギデンプン、アルギン酸ナトリウム、変性ポテトスターチ、カルボキシビニルポリマーなどがあげられる。 Examples of the water-soluble polymer include cellulose-based polymers such as hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, carboxymethyl cellulose sodium, xanthan gum, carrageenan, gum arabic, tragacanth gum, cationized guar gum, guar gum, gellan gum, locust bean. Examples include gums such as gums, dextran, sodium carboxymethyldextran, dextrin, gelatin, pectin, starch, corn starch, wheat starch, sodium alginate, modified potato starch, carboxyvinyl polymer, and the like.
前記水溶性高分子を含有する場合の含有量は、水性原液中0.01〜5質量%であることが好ましく、さらには0.05〜3質量%であることが好ましい。前記水溶性高分子の含有量が0.01質量%よりも少ない場合は水溶性高分子の効果が得られにくく、5質量%よりも多い場合は粘度が高くなり乳化しにくくなる傾向、使用感が悪くなる傾向がある。 When the water-soluble polymer is contained, the content in the aqueous stock solution is preferably 0.01 to 5% by mass, and more preferably 0.05 to 3% by mass. When the content of the water-soluble polymer is less than 0.01% by mass, it is difficult to obtain the effect of the water-soluble polymer. When the content is more than 5% by mass, the viscosity tends to be high and emulsification tends to be difficult. Tend to get worse.
前記pH調整剤は、水性原液のpHを調整して皮膚への刺激を低減させ、金属製のエアゾール容器を腐食しにくくするなどの目的で用いられる。 The pH adjuster is used for the purpose of adjusting the pH of the aqueous stock solution to reduce irritation to the skin and making the metal aerosol container difficult to corrode.
前記pH調整剤としては、たとえば、トリエタノールアミン(TEA)、ジエタノールアミン(DEA)、モノエタノールアミン(MEA)、ジイソプロパノールアミン(DIPA)、2−アミノ−2−メチル−1−プロパノール(AMP)、2−アミノ−2−メチル−1,3−プロパンジオール(AMPD)などの有機アルカリ、水酸化カリウム、水酸化ナトリウム、水酸化アンモニウムなどの無機アルカリ、クエン酸、クエン酸ナトリウム、グリコール酸、乳酸、リン酸などの有機酸、塩酸などの無機酸などがあげられる。 Examples of the pH adjuster include triethanolamine (TEA), diethanolamine (DEA), monoethanolamine (MEA), diisopropanolamine (DIPA), 2-amino-2-methyl-1-propanol (AMP), Organic alkalis such as 2-amino-2-methyl-1,3-propanediol (AMPD), inorganic alkalis such as potassium hydroxide, sodium hydroxide, ammonium hydroxide, citric acid, sodium citrate, glycolic acid, lactic acid, Examples thereof include organic acids such as phosphoric acid and inorganic acids such as hydrochloric acid.
前記pH調整剤を含有する場合、原液のpHが5〜9、さらには6〜8となるように含有することが好ましい。原液のpHが5よりも低い場合は容器が腐食されやすくなる傾向があり、pHが9よりも高くなると皮膚への刺激が強くなりやすくなる傾向がある。 When it contains the said pH adjuster, it is preferable to contain so that pH of a stock solution may be 5-9, Furthermore, 6-8. When the pH of the stock solution is lower than 5, the container tends to be corroded, and when the pH is higher than 9, irritation to the skin tends to become stronger.
前記油分は吐出物の状態を調整する、皮膚にうるおいを与えるなど、使用感を向上させる、水に溶解しにくい有効成分の溶媒としてなどの目的で用いられる。 The oil component is used for the purpose of improving the feeling of use such as adjusting the state of the discharged substance, giving moisture to the skin, and as an active ingredient solvent that is difficult to dissolve in water.
前記油分としては、メドウフォーム油、オリーブ油、ツバキ油、トウモロコシ油、ヒマシ油、サフラワー油、ホホバ油、ヤシ油などの油脂、ミリスチン酸、ステアリン酸、オレイン酸などの脂肪酸、セチルアルコール、オレイルアルコール、イソステアリルアルコールなどの高級アルコール、ミリスチン酸イソプロピル、パルミチン酸イソプロピル、イソオクタン酸セチル、ジネオペンタン酸メチルペンタンジオール、ジネオペンタン酸ジエチルペンタンジオール、ジ−2−エチルへキサン酸ネオペンチルグリコール、ジカプリン酸ネオペンチルグリコール、ジラウリン酸プロピレングリコール、ジステアリン酸エチレングリコール、モノステアリン酸プロピレングリコール、モノオレイン酸プロピレングリコール、モノステアリン酸エチレングリコール、トリ2−エチルへキサン酸グリセリル、トリ(カプリル・カプリン酸)グリセリン、イソノナン酸イソノニル、イソノナン酸イソトリデシル、コハク酸ジエトキシエチル、リンゴ酸ジイソステアリルなどのなどのエステル油、ジメチコン、メチルポリシロキサン、シクロペンタシロキサン、シクロヘキサシロキサン、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサシロキサン、メチルシクロポリシロキサン、テトラヒドロテトラメチルシクロテトラシロキサン、オクタメチルトリシロキサン、デカメチルテトラシロキサン、メチルハイドロジェンポリシロキサン、メチルフェニルポリシロキサンなどのシリコーンオイル、流動パラフィン、イソパラフィンなどの炭化水素、およびこれらの混合物などがあげられる。 Examples of the oils include oils such as meadow foam oil, olive oil, camellia oil, corn oil, castor oil, safflower oil, jojoba oil, coconut oil, fatty acids such as myristic acid, stearic acid, oleic acid, cetyl alcohol, oleyl alcohol , Higher alcohols such as isostearyl alcohol, isopropyl myristate, isopropyl palmitate, cetyl isooctanoate, methylpentanediol dineopentanoate, diethylpentanediol dineopentanoate, neopentyl glycol di-2-ethylhexanoate, neopentyl glycol dicaprate , Propylene glycol dilaurate, ethylene glycol distearate, propylene glycol monostearate, propylene glycol monooleate, ethyl stearate Ester oils such as glycol, glyceryl tri-2-ethylhexanoate, glyceryl tri (capryl / caprate), isononyl isononanoate, isotridecyl isononanoate, diethoxyethyl succinate, diisostearyl malate, etc., dimethicone, methylpoly Siloxane, cyclopentasiloxane, cyclohexasiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, methylcyclopolysiloxane, tetrahydrotetramethylcyclotetrasiloxane, octamethyltrisiloxane, decamethyltetrasiloxane, Silicone oils such as methyl hydrogen polysiloxane and methylphenyl polysiloxane, and hydrocarbons such as liquid paraffin and isoparaffin , And mixtures thereof, and the like.
前記油分を含有する場合の含有量は、水性原液中0.1〜20質量%であることが好ましく、さらには0.2〜10質量%であることが好ましい。前記油分の含有量が0.1質量%よりも少ない場合は前記油分の効果が得られにくくなる傾向があり、20質量%よりも多い場合は乾燥性が悪くなる、べたつきやすくなるなど使用感が低下する傾向がある。 When the oil component is contained, the content in the aqueous stock solution is preferably 0.1 to 20% by mass, and more preferably 0.2 to 10% by mass. When the content of the oil is less than 0.1% by mass, the effect of the oil tends to be difficult to be obtained. When the content is more than 20% by mass, the drying property is deteriorated and the feeling of stickiness is increased. There is a tendency to decrease.
前記その他のパウダー(水性原液と液化ガスとが分離している状態で水性原液と液化ガスとの間に存在しないパウダー)は、皮膚に塗布する際にすべりを良くする、サラサラ感を付与するなど使用感を向上させる目的で本願発明の効果を阻害しない程度であれば配合してもよい。 Other powders (powder that does not exist between the aqueous stock solution and the liquefied gas in a state where the aqueous stock solution and the liquefied gas are separated) improve slipperiness when applied to the skin, and give a smooth feeling. You may mix | blend if it is a grade which does not inhibit the effect of this invention for the purpose of improving a usability | use_condition.
水性原液と液化ガスとが分離している状態で水性原液と液化ガスとの間に存在しないパウダーとしては、水性原液と液化ガスの比重によるが、例えば真比重が0.10g/ml未満の各種パウダーや、真比重が0.80g/mlを超えるパウダーなどがあげられ、たとえば、タルク、カオリン、炭酸マグネシウム、炭酸カルシウム、ケイ酸亜鉛、ケイ酸マグネシウム、ケイ酸アルミニウム、ケイ酸カルシウム、真比重が0.10g/ml未満のシリカ、真比重が0.80g/mlよりも大きいシリカ、ゼオライト、セラミックパウダー、炭粉末、ナイロンパウダー、シルクパウダー、ウレタンパウダー、シリコーンパウダー、ポリエチレンパウダー、シリカビーズ、ガラスビーズ、樹脂ビーズなどがあげられる。 The powder that does not exist between the aqueous stock solution and the liquefied gas in a state where the aqueous stock solution and the liquefied gas are separated, depends on the specific gravity of the aqueous stock solution and the liquefied gas, for example, various kinds whose true specific gravity is less than 0.10 g / ml Examples include powders and powders whose true specific gravity exceeds 0.80 g / ml. For example, talc, kaolin, magnesium carbonate, calcium carbonate, zinc silicate, magnesium silicate, aluminum silicate, calcium silicate, true specific gravity is Silica less than 0.10 g / ml, silica with true specific gravity greater than 0.80 g / ml, zeolite, ceramic powder, charcoal powder, nylon powder, silk powder, urethane powder, silicone powder, polyethylene powder, silica beads, glass beads And resin beads.
前記水性原液は、界面活性剤および必要に応じて含有する有効成分や、水溶性高分子などを水に添加して混合し、これにパウダーを添加して分散させることにより調製することができる。なお、水性原液(パウダーを除く)の20℃における比重は0.85〜1.0g/mlであることが好ましい。 The aqueous stock solution can be prepared by adding a surfactant and, if necessary, an active ingredient, a water-soluble polymer, and the like to water and mixing, and then adding and dispersing the powder therein. In addition, it is preferable that specific gravity in 20 degreeC of aqueous | water-based stock solution (except powder) is 0.85-1.0 g / ml.
前記水の含有量は水性原液中50〜99.5質量%であることが好ましく、さらには55〜99.0質量%であることが好ましい。水の含有量が50質量%よりも少ない場合は液化ガスと乳化しにくくなる傾向があり、99.5質量%よりも多い場合は界面活性剤やパウダーを必要量含有しにくくなる。 The water content is preferably 50 to 99.5% by mass in the aqueous stock solution, more preferably 55 to 99.0% by mass. When the water content is less than 50% by mass, it tends to be difficult to emulsify with the liquefied gas, and when it is more than 99.5% by mass, it becomes difficult to contain the necessary amount of surfactant or powder.
前記水性原液の含有量は、エアゾール組成物中10〜60質量%であり、15〜55質量%であることが好ましい。水性原液の含有量が10質量%よりも少ない場合は水性原液と液化ガスとが分離しやすくなり、60質量%よりも多い場合はエアゾール組成物(乳化物)の比重が大きくなって、パウダーとの比重差が大きくなり、パウダーが浮遊しやすくなる傾向がある。 The content of the aqueous stock solution is 10 to 60% by mass in the aerosol composition, and preferably 15 to 55% by mass. When the content of the aqueous stock solution is less than 10% by mass, the aqueous stock solution and the liquefied gas are easily separated, and when the content is more than 60% by mass, the specific gravity of the aerosol composition (emulsion) increases, There is a tendency that the specific gravity difference of becomes large and the powder tends to float.
前記液化ガスはエアゾール容器内では蒸気圧を有する液体であり、水性原液と乳化している。エアゾール容器から外部に吐出されると気化し、吐出物を冷却して氷結する、または吐出物を発泡、破泡させてパチパチと弾ける感触を付与する、破泡音を発する、など、所望の吐出形態にする。 The liquefied gas is a liquid having a vapor pressure in an aerosol container and is emulsified with an aqueous stock solution. Vaporizes when discharged from the aerosol container, cools the discharged material and freezes, or foams and breaks the discharged material to give it a feel of crackling, and generates a desired sound Form it.
前記液化ガスとしては、例えば、プロパン(20℃における液比重:0.50g/ml)、ノルマルブタン(20℃における液比重:0.58g/ml)、イソブタン(20℃における液比重:0.56g/ml)、イソペンタン(20℃における液比重:0.62g/ml)、ノルマルペンタン(20℃における液比重:0.63g/ml)などの炭素数が3〜5個の炭化水素;ジメチルエーテル(20℃における液比重:0.66g/ml);トランス−1,3,3,3−テトラフルオロプロパ−1−エン(20℃における液比重:1.19g/ml)などのハイドロフルオロオレフィン;およびこれらの混合物;などがあげられる。なかでも、水性原液と乳化しやすい点から炭素数が3〜5個の炭化水素、ハイドロフルオロオレフィンなどの親油性液化ガスを用いることが好ましく、特に、比重が小さく、パウダーの真比重との差が小さい炭素数が3〜5個の炭化水素を用いることが好ましい。なお、液化ガスの20℃における比重は0.50〜0.70g/mlが好ましい。 Examples of the liquefied gas include propane (liquid specific gravity at 20 ° C .: 0.50 g / ml), normal butane (liquid specific gravity at 20 ° C .: 0.58 g / ml), and isobutane (liquid specific gravity at 20 ° C .: 0.56 g). Hydrocarbons having 3 to 5 carbon atoms such as isopentane (liquid specific gravity at 20 ° C .: 0.62 g / ml), normal pentane (liquid specific gravity at 20 ° C .: 0.63 g / ml); dimethyl ether (20 Liquid specific gravity at 0 ° C .: 0.66 g / ml); hydrofluoroolefins such as trans-1,3,3,3-tetrafluoroprop-1-ene (liquid specific gravity at 20 ° C .: 1.19 g / ml); and these And the like. Among these, it is preferable to use a lipophilic liquefied gas such as a hydrocarbon having 3 to 5 carbon atoms or hydrofluoroolefin from the viewpoint of easy emulsification with an aqueous stock solution, and in particular, the specific gravity is small and the difference from the true specific gravity of the powder. It is preferable to use a hydrocarbon having a small carbon number of 3 to 5. The specific gravity of the liquefied gas at 20 ° C. is preferably 0.50 to 0.70 g / ml.
前記液化ガスの含有量は、エアゾール組成物中40〜90質量%が好ましく、さらには45〜85質量%が好ましい。液化ガスの含有量が40質量%よりも少ない場合はエアゾール組成物(乳化物)の比重が大きくなり、パウダーの真比重との差が大きくなってパウダーが浮遊しやすくなり、90質量%よりも多い場合は水性原液と液化ガスとが分離しやすくなる傾向がある。 The content of the liquefied gas is preferably 40 to 90% by mass, more preferably 45 to 85% by mass in the aerosol composition. When the content of the liquefied gas is less than 40% by mass, the specific gravity of the aerosol composition (emulsion) is increased, the difference from the true specific gravity of the powder is increased, and the powder is liable to float, more than 90% by mass. When the amount is large, the aqueous stock solution and the liquefied gas tend to be easily separated.
また、前記液化ガス以外に、容器内の圧力の調整、吐出状態の調整などを目的として圧縮ガスを含有することができる。圧縮ガスとしては、例えば、炭酸ガス、亜酸化窒素ガス、窒素ガス、圧縮空気などを含有することができる。 In addition to the liquefied gas, a compressed gas can be contained for the purpose of adjusting the pressure in the container and adjusting the discharge state. As compressed gas, carbon dioxide gas, nitrous oxide gas, nitrogen gas, compressed air, etc. can be contained, for example.
本発明の乳化型エアゾール組成物は、水性原液を耐圧容器に充填し、液化ガスをアンダーカップ充填した後、耐圧容器にエアゾールバルブを固着して密封し、エアゾール容器を振盪して水性原液と液化ガスとを乳化させることにより製造することができる。なお、水性原液を充填したのちにディップチューブ付きのエアゾールバルブを耐圧容器に固着し、エアゾールバルブから液化ガスを充填しても良い。この場合、液化ガスの充填により水性原液とエアゾール容器内で混合されて乳化が進むため、振盪工程をさらに容易または不要とすることができる。 The emulsified aerosol composition of the present invention is filled with an aqueous stock solution and filled with a liquefied gas under a cup, and then sealed with an aerosol valve fixed to the pressure vessel, and the aerosol container is shaken to liquefy the aqueous stock solution. It can manufacture by emulsifying gas. In addition, after filling the aqueous stock solution, an aerosol valve with a dip tube may be fixed to the pressure vessel, and the liquefied gas may be filled from the aerosol valve. In this case, since the emulsification proceeds by mixing the aqueous stock solution and the aerosol container by filling the liquefied gas, the shaking step can be further facilitated or made unnecessary.
本発明の乳化型エアゾール組成物は、パウダーを含有し、水性原液と液化ガスとが分離している状態で、パウダーが水性原液と液化ガスとの間に存在するため初期乳化しやすく、長期間静置してもパウダーが容器底部に沈降して固まる(ケーキング)ことがなく、消費者が使用するときに軽く振るだけで製造直後の乳化状態に戻り、設計通りの吐出物の効果が得られることから、やけど治療薬、消炎鎮痛剤、鎮痒剤、皮膚保護剤、抗真菌剤、制汗剤、収斂剤、ほてり止め、冷却剤、日焼け止め、忌避剤、シャンプー、ヘアトリートメント、育毛剤などの皮膚や毛髪に塗布する人体用製品、芳香剤、消臭剤、花粉除去剤などの空間用製品などに好適に用いることができる。また、ポリエチレンテレフタレートなどの透明な合成樹脂製の容器に充填しても外観を損なわないため、エアゾール組成物の外観を利用したデザインにすることができ、残量を目視で確認することができる。 The emulsified aerosol composition of the present invention contains a powder, and in a state where the aqueous stock solution and the liquefied gas are separated, since the powder exists between the aqueous stock solution and the liquefied gas, it is easy to perform initial emulsification for a long time. Even if left standing, the powder does not settle and harden (caking) at the bottom of the container, and when the consumer uses it, just shake it lightly to return to the emulsified state immediately after production, and the effect of the discharged product as designed is obtained. Therefore, burn treatment, anti-inflammatory analgesic, antipruritic, skin protectant, antifungal, antiperspirant, astringent, anti-hot flash, cooling agent, sunscreen, repellent, shampoo, hair treatment, hair restorer, etc. It can be suitably used for space products such as human products, fragrances, deodorants and pollen removers applied to the skin and hair. Moreover, since it does not impair the external appearance even if it is filled in a transparent synthetic resin container such as polyethylene terephthalate, it can be designed using the external appearance of the aerosol composition, and the remaining amount can be confirmed visually.
以下、実施例によって本発明をより具体的に説明するが、本発明はこれらに限定されるものではない。 EXAMPLES Hereinafter, although an Example demonstrates this invention more concretely, this invention is not limited to these.
評価方法を下記に示す。 The evaluation method is shown below.
(1)乳化前のエアゾール組成物の状態
透明なガラス製耐圧容器(満注量100ml)を用いた試験用エアゾール製品を25℃の恒温室内に1日静置し、外観を下記基準で評価した。
○:パウダーが水性原液と液化ガスとの間に存在していた。
△:パウダーが水性原液中に浮遊し、一部が容器底部に沈降していた。
×:パウダーが容器底部に沈降していた。
(1) State of aerosol composition before emulsification A test aerosol product using a transparent glass pressure-resistant container (full volume 100 ml) was left in a thermostatic chamber at 25 ° C. for one day, and the appearance was evaluated according to the following criteria. .
○: The powder was present between the aqueous stock solution and the liquefied gas.
(Triangle | delta): Powder floated in the aqueous | water-based stock solution, and a part was settled to the container bottom part.
X: The powder had settled to the container bottom part.
(2)初期乳化
アルミニウム製耐圧容器(満注量100ml)を用いた各試験用エアゾール製品および各基準品を手で持ち、30cmの幅で上下に振り、1往復を1回として乳化するまでの回数を数え、各基準品の回数と各実施例および比較例の回数とを比較し、下記基準で評価した。
○:基準品の40%以下
△:基準品の41〜60%
×:基準品の61%以上
(2) Initial emulsification Hold each test aerosol product and each reference product using a pressure vessel made of aluminum (filled volume: 100 ml) by hand, swing up and down with a width of 30 cm, and emulsify with one reciprocation as one time The number of times was counted, the number of each reference product was compared with the number of each example and comparative example, and the following criteria were evaluated.
○: 40% or less of standard product △: 41-60% of standard product
×: 61% or more of standard products
(3)再乳化
初期乳化試験に供したエアゾール製品を45℃の恒温室内に3箇月間静置し、このエアゾール製品を手に持ち、30cmの幅で上下に振り、1往復を1回として乳化するまでの回数を数え、下記基準で評価した。
○:3回振ると乳化した。
△:4〜10回振ると乳化した。
×:10回振っても乳化しなかった。
(3) Re-emulsification The aerosol product subjected to the initial emulsification test was left in a constant temperature room at 45 ° C for 3 months, and this aerosol product was held in the hand and shaken up and down with a width of 30cm, emulsifying one round trip. The number of times until this was counted and evaluated according to the following criteria.
○: Emulsified when shaken 3 times.
Δ: Emulsified when shaken 4 to 10 times.
X: It did not emulsify even if shaken 10 times.
(4)再分散性(ケーキングの有無)
透明なガラス製耐圧容器(満注量100ml)を用いた試験用エアゾール製品を、水性原液と液化ガスとを乳化させた後、40℃の恒温室内に3箇月間静置し、このエアゾール製品を手に持ち、30cmの幅で上下に振り、1往復を1回としてパウダーが分散するまでの回数を数え、下記基準で評価した。
○:3回振るとパウダーが均一に分散した。
△:4〜10回振るとパウダーが均一に分散した。
×:10回振っても均一に分散しなかった。
(4) Redispersibility (with or without caking)
A test aerosol product using a transparent glass pressure vessel (full volume 100 ml) was emulsified with an aqueous stock solution and a liquefied gas, and then left in a constant temperature room at 40 ° C. for 3 months. It was held in hand, swung up and down with a width of 30 cm, one round trip was counted as one count, and the number of times until the powder was dispersed was counted and evaluated according to the following criteria.
○: The powder was uniformly dispersed when shaken 3 times.
Δ: The powder was uniformly dispersed when shaken 4 to 10 times.
X: Even if shaken 10 times, it was not uniformly dispersed.
実施例1〜5、比較例1〜3および基準品1<氷結タイプ>
表1に示す各水性原液を調製し、得られた水性原液を透明なガラス製耐圧容器およびアルミニウム製耐圧容器(いずれも満注量100ml)に10g(25質量%)ずつ充填し、エアゾールバルブを固着した。次いでチューブを備えていないエアゾールバルブから液化ガスを30g(75質量%)ずつ充填し、水性原液と液化ガスとが分離している試験用エアゾール製品を製造した。また、パウダーを精製水に置き換えたパウダーを配合しない水性原液を用いたエアゾール製品を基準品1(アルミニウム製耐圧容器使用)として製造した。得られた試験用エアゾール製品について前記(1)〜(4)の評価を行った。評価結果を表2に示す。
Examples 1 to 5, Comparative Examples 1 to 3 and reference product 1 <Freezing type>
Each aqueous undiluted solution shown in Table 1 was prepared, and the obtained aqueous undiluted solution was filled in 10 g (25% by mass) each in a transparent glass pressure-resistant vessel and an aluminum pressure-resistant vessel (both filled amounts of 100 ml). Stuck. Next, 30 g (75% by mass) of liquefied gas was filled from an aerosol valve not equipped with a tube to produce a test aerosol product in which the aqueous stock solution and liquefied gas were separated. Moreover, the aerosol product using the aqueous | water-based stock solution which does not mix | blend the powder which replaced the powder with the purified water was manufactured as the reference | standard product 1 (use a pressure-resistant container made from aluminum). Evaluation of said (1)-(4) was performed about the obtained aerosol product for a test. The evaluation results are shown in Table 2.
*2:NIKKOL PBC−44(商品名)、日光ケミカルズ株式会社製
*3:HEC SE850(商品名)、ダイセルファインケム株式会社製
*4:SILICA MICRO BEAD BA−1(商品名)、日揮触媒化成株式会社製(真比重:0.5g/ml、比表面積:1m2/g、親水性、中空シリカビーズ)
*5:3MグラスバブルズK20(商品名)住友スリーエム株式会社製
(真比重:0.2g/ml、比表面積:60m2/g、親水性、中空ガラスビーズ)
*6:3MグラスバブルズS38(商品名)住友スリーエム株式会社製
(真比重:0.38g/ml、比表面積:40m2/g、親水性、中空ガラスビーズ)
*7:3MグラスバブルズS60HS(商品名)住友スリーエム株式会社製
(真比重:0.6g/ml、比表面積:24m2/g、親水性、中空ガラスビーズ)
*8:マツモトマイクロスフェアー M−600(商品名)、松本油脂製薬株式会社製(真比重:0.9g/ml、比表面積:8m2/g、親水性、中空樹脂ビーズ)
*9:クラウンタルクPP(商品名)、松村産業株式会社製
(真比重:2.7g/ml、比表面積:1.5m2/g、親水性)
*10:サイリシア710(商品名)、富士シリシア化学株式会社製
(真比重:2.2g/ml、比表面積:700m2/g、親水性、多孔質シリカ)
*11:アエロジル#200(商品名)、日本アエロジル株式会社製
(真比重:2.2g/ml、比表面積:200m2/g、親水性、多孔質シリカ)
* 2: NIKKOL PBC-44 (trade name), manufactured by Nikko Chemicals Co., Ltd. * 3: HEC SE850 (trade name), manufactured by Daicel Finechem Co., Ltd. * 4: SILICA MICRO BEAD BA-1 (trade name), JGC Catalysts & Chemicals Co., Ltd. Made by company (true specific gravity: 0.5 g / ml, specific surface area: 1 m 2 / g, hydrophilic, hollow silica beads)
* 5: 3M Glass Bubbles K20 (trade name) manufactured by Sumitomo 3M Limited (true specific gravity: 0.2 g / ml, specific surface area: 60 m 2 / g, hydrophilic, hollow glass beads)
* 6: 3M Glass Bubbles S38 (trade name) manufactured by Sumitomo 3M Limited (true specific gravity: 0.38 g / ml, specific surface area: 40 m 2 / g, hydrophilic, hollow glass beads)
* 7: 3M Glass Bubbles S60HS (trade name) manufactured by Sumitomo 3M Limited (true specific gravity: 0.6 g / ml, specific surface area: 24 m 2 / g, hydrophilic, hollow glass beads)
* 8: Matsumoto Microsphere M-600 (trade name), manufactured by Matsumoto Yushi Seiyaku Co., Ltd. (true specific gravity: 0.9 g / ml, specific surface area: 8 m 2 / g, hydrophilic, hollow resin beads)
* 9: Crown talc PP (trade name), manufactured by Matsumura Sangyo Co., Ltd. (true specific gravity: 2.7 g / ml, specific surface area: 1.5 m 2 / g, hydrophilic)
* 10: Silicia 710 (trade name), manufactured by Fuji Silysia Chemical Ltd. (true specific gravity: 2.2 g / ml, specific surface area: 700 m 2 / g, hydrophilic, porous silica)
* 11: Aerosil # 200 (trade name), manufactured by Nippon Aerosil Co., Ltd. (true specific gravity: 2.2 g / ml, specific surface area: 200 m 2 / g, hydrophilic, porous silica)
実施例6〜8、比較例4〜6および基準品2<弾ける泡タイプ>
表3に示す各水性原液を調製し、得られた水性原液を透明なガラス製耐圧容器およびアルミニウム製耐圧容器(いずれも満注量100ml)に12g(30質量%)ずつ充填し、エアゾールバルブを固着した。次いでチューブを備えていないエアゾールバルブから液化ガスを28g(70質量%)ずつ充填し、水性原液と液化ガスとが分離している試験用エアゾール製品を製造した。また、パウダーを精製水に置き換えたパウダーを配合しない水性原液を用いたエアゾール製品を基準品2(アルミニウム製耐圧容器使用)として製造した。得られた試験用エアゾール製品について前記(1)〜(4)の評価を行った。評価結果を表4に示す。
Examples 6 to 8, Comparative Examples 4 to 6 and reference product 2 <Floating foam type>
Each aqueous undiluted solution shown in Table 3 was prepared, and the obtained aqueous undiluted solution was filled into a transparent glass pressure vessel and an aluminum pressure vessel (both filled 100 ml) at a rate of 12 g (30% by mass). Stuck. Next, 28 g (70% by mass) of liquefied gas was filled from an aerosol valve not equipped with a tube to produce a test aerosol product in which the aqueous stock solution and liquefied gas were separated. Moreover, the aerosol product using the aqueous | water-based stock solution which does not mix | blend the powder which replaced the powder with the purified water was manufactured as the reference | standard product 2 (pressure-resistant container made from aluminum). Evaluation of said (1)-(4) was performed about the obtained aerosol product for a test. The evaluation results are shown in Table 4.
*13:TS−10V(商品名)、日光ケミカルズ株式会社製
実施例9〜11、比較例7〜9および基準品3<弾けるジェルタイプ>
表5に示す各水性原液を調製し、得られた水性原液を透明なガラス製耐圧容器およびアルミニウム製耐圧容器(いずれも満注量100ml)に16g(40質量%)ずつ充填し、エアゾールバルブを固着した。次いでチューブを備えていないエアゾールバルブから液化ガスを24g(60質量%)ずつ充填し、水性原液と液化ガスとが分離している試験用エアゾール製品を製造した。また、パウダーを精製水に置き換えたパウダーを配合しない水性原液を用いたエアゾール製品を基準品3(アルミニウム製耐圧容器使用)として製造した。得られた試験用エアゾール製品について前記(1)〜(4)の評価を行った。評価結果を表6に示す。
Examples 9 to 11, Comparative Examples 7 to 9 and Reference Product 3 <Flipable Gel Type>
Each aqueous undiluted solution shown in Table 5 was prepared, and the obtained aqueous undiluted solution was filled into a transparent glass pressure vessel and an aluminum pressure vessel (both 100 ml) in an amount of 16 g (40% by mass). Stuck. Next, 24 g (60% by mass) of liquefied gas was charged from an aerosol valve not equipped with a tube to produce a test aerosol product in which the aqueous stock solution and the liquefied gas were separated. Moreover, the aerosol product using the aqueous | water-based stock solution which does not mix | blend the powder which replaced the powder with the purified water was manufactured as the reference | standard product 3 (pressure-resistant container made from aluminum). Evaluation of said (1)-(4) was performed about the obtained aerosol product for a test. The evaluation results are shown in Table 6.
処方例1 冷却剤<氷結タイプ>
下記の原液17.5g(25質量%)をブリキ製耐圧容器(満注量:200ml)に充填し、エアゾールバルブを固着し、エアゾールバルブから液化ガス(*1)52.5g(75質量%)を充填してエアゾール製品を製造した。また、下記の原液8.75g(25質量%)を透明なガラス製耐圧容器(満注量:100ml)に充填し、エアゾールバルブを固着し、エアゾールバルブから液化ガス(*1)26.25g(75質量%)を充填してエアゾール製品を製造した。得られたエアゾール製品について上記の評価を行った。評価結果を表7に示す。なお、下記原液からパウダーを抜いた原液を用いたものを基準品として評価した。
Formulation Example 1 Coolant <Freeze Type>
Fill 17.5 g (25% by mass) of the following stock solution into a pressure-resistant container made of tinplate (full injection amount: 200 ml), fix the aerosol valve, and 52.5 g (75% by mass) of liquefied gas (* 1) from the aerosol valve. To produce an aerosol product. In addition, 8.75 g (25% by mass) of the following stock solution is filled in a transparent glass pressure-resistant container (full amount: 100 ml), an aerosol valve is fixed, and 26.25 g of liquefied gas (* 1) from the aerosol valve ( 75% by mass) to produce an aerosol product. Said evaluation was performed about the obtained aerosol product. Table 7 shows the evaluation results. In addition, what used the undiluted | stock solution which extracted powder from the following undiluted | stock solution was evaluated as a reference | standard product.
<原液>
POE(20)POP(8)セチルエーテル(*2) 0.5
シリカ(*4) 0.5
ヒドロキシエチルセルロース(*3) 0.1
メチルパラベン 0.1
l−メントール 0.1
安息香酸ナトリウム 0.1
精製水 98.6
合計(質量%) 100.0
<Undiluted solution>
POE (20) POP (8) Cetyl ether (* 2) 0.5
Silica (* 4) 0.5
Hydroxyethyl cellulose (* 3) 0.1
Methylparaben 0.1
l-Menthol 0.1
Sodium benzoate 0.1
Purified water 98.6
Total (mass%) 100.0
処方例2 ファンデーション<氷結タイプ>
下記の原液12g(30質量%)を透明なガラス製耐圧容器およびアルミニウム製耐圧容器(いずれも満注量:100ml)に充填し、エアゾールバルブを固着した。そして、エアゾールバルブから液化ガス(*1)26g(65質量%)を充填し、さらにジメチルエーテル2g(5質量%)を充填しエアゾール製品を製造した。得られたエアゾール製品について上記の評価を行った。評価結果を表7に示す。なお、下記原液からパウダーを抜いた原液を用いたものを基準品として評価した。
Formulation Example 2 Foundation <Freeze Type>
12 g (30% by mass) of the following stock solution was filled in a transparent glass pressure vessel and an aluminum pressure vessel (both filled: 100 ml), and an aerosol valve was fixed. Then, 26 g (65% by mass) of liquefied gas (* 1) was filled from the aerosol valve, and further 2 g (5% by mass) of dimethyl ether was filled to produce an aerosol product. Said evaluation was performed about the obtained aerosol product. Table 7 shows the evaluation results. In addition, what used the undiluted | stock solution which extracted powder from the following undiluted | stock solution was evaluated as a reference | standard product.
<原液>
POE(20)POP(8)セチルエーテル(*2) 0.5
シリカ(*4) 0.5
ヒドロキシエチルセルロース(*3) 0.1
メチルパラベン 0.1
顔料 15.0
パラジメチルアミノ安息香酸2−エチルヘキシル(*15) 3.0
オリーブ油(*16) 2.0
スクワラン(*17) 1.0
エタノール 5.0
香料 0.1
精製水 72.7
合計(質量%) 100.0
*15:エスカロール507(商品名)、ISPジャパン株式会社製
*16:クロダモル OL(商品名)、クローダジャパン株式会社製
*17:スクワラン(商品名)、日光ケミカルズ株式会社製
<Undiluted solution>
POE (20) POP (8) Cetyl ether (* 2) 0.5
Silica (* 4) 0.5
Hydroxyethyl cellulose (* 3) 0.1
Methylparaben 0.1
Pigment 15.0
2-Ethylhexyl paradimethylaminobenzoate (* 15) 3.0
Olive oil (* 16) 2.0
Squalane (* 17) 1.0
Ethanol 5.0
Fragrance 0.1
Purified water 72.7
Total (mass%) 100.0
* 15: Escalol 507 (trade name), manufactured by ISP Japan Co., Ltd. * 16: Kurodamol OL (trade name), manufactured by Coda Japan Co., Ltd. * 17: Squalane (trade name), manufactured by Nikko Chemicals Co., Ltd.
処方例3 冷感シャンプー<氷結タイプ>
下記の原液12g(30質量%)を透明なガラス製耐圧容器およびアルミニウム製耐圧容器(いずれも満注量:100ml)に充填し、エアゾールバルブを固着した。そして、エアゾールバルブから液化ガス(*1)10g(25質量%)を充填し、さらにジメチルエーテル18g(45質量%)を充填しエアゾール製品を製造した。得られたエアゾール製品について上記の評価を行った。評価結果を表7に示す。なお、下記原液からパウダーを抜いた原液を用いたものを基準品として評価した。
Formulation Example 3 Cold Shampoo <Freeze Type>
12 g (30% by mass) of the following stock solution was filled in a transparent glass pressure vessel and an aluminum pressure vessel (both filled: 100 ml), and an aerosol valve was fixed. And 10g (25 mass%) of liquefied gas (* 1) was filled from the aerosol valve | bulb, and also 18g (45 mass%) of dimethyl ether was filled, and the aerosol product was manufactured. Said evaluation was performed about the obtained aerosol product. Table 7 shows the evaluation results. In addition, what used the undiluted | stock solution which extracted powder from the following undiluted | stock solution was evaluated as a reference | standard product.
<原液>
ラウロイルサルコシンナトリウム(*18) 10.0
ポリオキシエチレン(20)オレイルエーテル(*19) 5.0
ポリオキシエチレンラウリルエーテル硫酸ナトリウム(*20) 10.0
シリカ(*4) 0.5
ヒドロキシエチルセルロース(*3) 0.5
ポリクオタニウム−10(*21) 0.1
ヒアルロン酸ヒドロキシプロピルトリモニウム(*22) 3.0
ジグリセリン(*23) 2.0
加水分解ハチミツタンパク(*24) 1.0
リンゴ酸(*25) 0.2
メチルパラベン 0.1
精製水 67.6
合計(質量%) 100.0
*18:ソイポンSLE(商品名)、川研ファインケミカル株式会社製
*19:NIKKOL BO−20V(商品名)、日光ケミカルズ株式会社製
*20:エマール270J(商品名)、花王株式会社製
*21:マーコート10(商品名)、ナルコジャパン株式会社製
*22:ヒアロベール(商品名)、キューピー株式会社製
*23:ジグリセリン 801(商品名)、阪本薬品工業株式会社製
*24:ハニーテイン(商品名)、片倉チッカリン株式会社製
*25:リンゴ酸フソウM(商品名)、扶桑化学化学工業株式会社製
<Undiluted solution>
Lauroyl sarcosine sodium (* 18) 10.0
Polyoxyethylene (20) oleyl ether (* 19) 5.0
Sodium polyoxyethylene lauryl ether sulfate (* 20) 10.0
Silica (* 4) 0.5
Hydroxyethyl cellulose (* 3) 0.5
Polyquaternium-10 (* 21) 0.1
Hydroxypropyltrimonium hyaluronate (* 22) 3.0
Diglycerin (* 23) 2.0
Hydrolyzed honey protein (* 24) 1.0
Malic acid (* 25) 0.2
Methylparaben 0.1
Purified water 67.6
Total (mass%) 100.0
* 18: Soypon SLE (trade name), manufactured by Kawaken Fine Chemical Co., Ltd. * 19: NIKKOL BO-20V (trade name), manufactured by Nikko Chemicals Co., Ltd. * 20: Emar 270J (trade name), manufactured by Kao Corporation * 21: Marcote 10 (trade name), manufactured by Nalco Japan Co., Ltd. * 22: Hyarobale (trade name), manufactured by Kewpie Co., Ltd. * 23: Diglycerin 801 (trade name), manufactured by Sakamoto Pharmaceutical Co., Ltd. * 24: Honeytain (trade name) ), Manufactured by Katakura Chikkarin Co., Ltd. * 25: Fuso-malate M (trade name), manufactured by Fuso Chemical Chemical Co., Ltd.
処方例4 ボディ用化粧水<弾けるジェルタイプ>
下記の原液16g(40質量%)を透明なガラス製耐圧容器およびアルミニウム製耐圧容器(いずれも満注量:100ml)に充填し、エアゾールバルブを固着した。そして、エアゾールバルブから液化ガス(*1)24g(60質量%)を充填し、さらにエアゾールバルブから、炭酸ガスを平衡圧で0.6MPaとなるように充填してエアゾール製品を製造した。得られたエアゾール製品について上記の評価を行った。評価結果を表7に示す。なお、下記原液からパウダーを抜いた原液を用いたものを基準品として評価した。
Formulation Example 4 Body Lotion <Flipable Gel Type>
16 g (40 mass%) of the following stock solution was filled in a transparent glass pressure vessel and an aluminum pressure vessel (both filled: 100 ml), and an aerosol valve was fixed. Then, 24 g (60% by mass) of liquefied gas (* 1) was filled from the aerosol valve, and further, an aerosol product was produced by filling carbon dioxide gas from the aerosol valve so that the equilibrium pressure was 0.6 MPa. Said evaluation was performed about the obtained aerosol product. Table 7 shows the evaluation results. In addition, what used the undiluted | stock solution which extracted powder from the following undiluted | stock solution was evaluated as a reference | standard product.
<原液>
PEG−20ソルビタンココエート(*12) 0.5
シリカ(*4) 0.5
ヒドロキシエチルセルロース(*3) 0.5
メチルパラベン 0.1
シクロペンタシロキサン(*14) 5.0
グリセリン 3.0
l−メントール 0.1
ヒアルロン酸 0.5
エタノール 20.0
精製水 69.8
合計(質量%) 100.0
<Undiluted solution>
PEG-20 sorbitan cocoate (* 12) 0.5
Silica (* 4) 0.5
Hydroxyethyl cellulose (* 3) 0.5
Methylparaben 0.1
Cyclopentasiloxane (* 14) 5.0
Glycerin 3.0
l-Menthol 0.1
Hyaluronic acid 0.5
Ethanol 20.0
Purified water 69.8
Total (mass%) 100.0
処方例5 ヘアトリートメント<弾ける泡タイプ>
下記の原液12g(30質量%)を透明なガラス製耐圧容器およびアルミニウム製耐圧容器(いずれも満注量:100ml)に充填し、エアゾールバルブを固着した。そして、エアゾールバルブから液化ガス(*1)28g(70質量%)を充填し、さらにエアゾールバルブから、炭酸ガスを平衡圧で0.6MPaとなるように充填してエアゾール製品を製造した。得られたエアゾール製品について上記の評価を行った。評価結果を表7に示す。なお、下記原液からパウダーを抜いた原液を用いたものを基準品として評価した。
Formulation 5 Hair Treatment <Floating Foam Type>
12 g (30% by mass) of the following stock solution was filled in a transparent glass pressure vessel and an aluminum pressure vessel (both filled: 100 ml), and an aerosol valve was fixed. Then, 28 g (70% by mass) of liquefied gas (* 1) was filled from the aerosol valve, and further, an aerosol product was produced by filling the carbon dioxide gas from the aerosol valve so that the equilibrium pressure was 0.6 MPa. Said evaluation was performed about the obtained aerosol product. Table 7 shows the evaluation results. In addition, what used the undiluted | stock solution which extracted powder from the following undiluted | stock solution was evaluated as a reference | standard product.
<原液>
POE(20)セチルエーテル(*26) 2.0
POE硬化ヒマシ油(*27) 2.0
シリカ(*4) 0.5
メチルパラベン 0.1
ジネオペンタン酸メチルペンタンジオール(*28) 3.0
ジメチコン(*29) 1.0
プロピレングリコール 3.0
塩化セチルトリメチルアンモニウム(*30) 0.5
l−メントール 0.1
香料 0.1
エタノール 10.0
精製水 77.7
合計(質量%) 100.0
*26:NIKKOL BC−20(商品名)、日光ケミカルズ株式会社製
*27:NIKKOL HCO−60(商品名)、日光ケミカルズ株式会社製
*28:Neosolue MP(商品名)、日本精化株式会社製
*29:SH 200(商品名)、東レ・ダウコーニング株式会社製
*30:カチナールCTC−70ET(商品名)、東邦化学工業株式会社製
<Undiluted solution>
POE (20) cetyl ether (* 26) 2.0
POE hydrogenated castor oil (* 27) 2.0
Silica (* 4) 0.5
Methylparaben 0.1
Dineopentanoic acid methylpentanediol (* 28) 3.0
Dimethicone (* 29) 1.0
Propylene glycol 3.0
Cetyltrimethylammonium chloride (* 30) 0.5
l-Menthol 0.1
Fragrance 0.1
Ethanol 10.0
Purified water 77.7
Total (mass%) 100.0
* 26: NIKKOL BC-20 (trade name), manufactured by Nikko Chemicals Co., Ltd. * 27: NIKKOL HCO-60 (trade name), manufactured by Nikko Chemicals Co., Ltd. * 28: Neosolute MP (trade name), manufactured by Nippon Seika Co., Ltd. * 29: SH 200 (trade name), manufactured by Toray Dow Corning Co., Ltd. * 30: Kachinar CTC-70ET (trade name), manufactured by Toho Chemical Industry Co., Ltd.
処方例6 育毛剤<弾ける泡タイプ>
下記の原液12g(30質量%)を透明なガラス製耐圧容器およびアルミニウム製耐圧容器(いずれも満注量:100ml)に充填し、エアゾールバルブを固着した。そして、エアゾールバルブから液化ガス(*1)28g(70質量%)を充填してエアゾール製品を製造した。得られたエアゾール製品について上記の評価を行った。評価結果を表7に示す。なお、下記原液からパウダーを抜いた原液を用いたものを基準品として評価した。
Formulation Example 6 Hair restorer <Floating foam type>
12 g (30% by mass) of the following stock solution was filled in a transparent glass pressure vessel and an aluminum pressure vessel (both filled: 100 ml), and an aerosol valve was fixed. And aerosol product was manufactured by filling 28g (70 mass%) of liquefied gas (* 1) from the aerosol valve | bulb. Said evaluation was performed about the obtained aerosol product. Table 7 shows the evaluation results. In addition, what used the undiluted | stock solution which extracted powder from the following undiluted | stock solution was evaluated as a reference | standard product.
<原液>
POE(20)POP(8)セチルエーテル(*2) 1.0
シリカ(*4) 0.5
ヒドロキシエチルセルロース(*3) 0.5
メチルパラベン 0.1
プロピレングリコール 2.0
グリチルリチン酸ジカリウム 0.5
l−メントール 0.1
センブリエキス 0.1
イチョウエキス 0.1
アロエ抽出液 0.1
ミノキシジル 1.0
ヒアルロン酸 0.1
香料 0.1
エタノール 20.0
精製水 73.8
合計(質量%) 100.0
<Undiluted solution>
POE (20) POP (8) Cetyl ether (* 2) 1.0
Silica (* 4) 0.5
Hydroxyethyl cellulose (* 3) 0.5
Methylparaben 0.1
Propylene glycol 2.0
Dipotassium glycyrrhizinate 0.5
l-Menthol 0.1
Assembly extract 0.1
Ginkgo biloba 0.1
Aloe extract 0.1
Minoxidil 1.0
Hyaluronic acid 0.1
Fragrance 0.1
Ethanol 20.0
Purified water 73.8
Total (mass%) 100.0
処方例7 育毛剤<弾ける泡タイプ>
下記の原液12g(30質量%)を透明なガラス製耐圧容器およびアルミニウム製耐圧容器(いずれも満注量:100ml)に充填し、エアゾールバルブを固着した。そして、エアゾールバルブから液化ガス(*1)22g(55質量%)を充填し、さらにジメチルエーテル6g(15質量%)を充填しエアゾール製品を製造した。得られたエアゾール製品について上記の評価を行った。評価結果を表7に示す。なお、下記原液からパウダーを抜いた原液を用いたものを基準品として評価した。
Formulation Example 7 Hair restorer <Floating foam type>
12 g (30% by mass) of the following stock solution was filled in a transparent glass pressure vessel and an aluminum pressure vessel (both filled: 100 ml), and an aerosol valve was fixed. Then, 22 g (55% by mass) of liquefied gas (* 1) was filled from the aerosol valve, and 6 g (15% by mass) of dimethyl ether was further filled to produce an aerosol product. Said evaluation was performed about the obtained aerosol product. Table 7 shows the evaluation results. In addition, what used the undiluted | stock solution which extracted powder from the following undiluted | stock solution was evaluated as a reference | standard product.
<原液>
POE(20)POP(8)セチルエーテル(*2) 0.5
シリカ(*4) 0.5
ヒドロキシエチルセルロース(*3) 0.5
メチルパラベン 0.1
プロピレングリコール 3.0
グリチルリチン酸ジカリウム 0.5
l−メントール 0.1
センブリエキス 0.1
ヒアルロン酸ナトリウム 0.1
香料 0.1
エタノール 20.0
精製水 74.5
合計(質量%) 100.0
<Undiluted solution>
POE (20) POP (8) Cetyl ether (* 2) 0.5
Silica (* 4) 0.5
Hydroxyethyl cellulose (* 3) 0.5
Methylparaben 0.1
Propylene glycol 3.0
Dipotassium glycyrrhizinate 0.5
l-Menthol 0.1
Assembly extract 0.1
Sodium hyaluronate 0.1
Fragrance 0.1
Ethanol 20.0
Purified water 74.5
Total (mass%) 100.0
処方例8 害虫忌避剤<弾ける泡タイプ>
下記の原液12g(30質量%)を透明なガラス製耐圧容器およびアルミニウム製耐圧容器(いずれも満注量:100ml)に充填し、エアゾールバルブを固着した。そして、エアゾールバルブから液化ガス(*1)22g(55質量%)を充填し、さらにジメチルエーテル6g(15質量%)を充填しエアゾール製品を製造した。得られたエアゾール製品について上記の評価を行った。評価結果を表7に示す。なお、下記原液からパウダーを抜いた原液を用いたものを基準品として評価した。
Formulation Example 8 Pest Repellent <Floating Foam Type>
12 g (30% by mass) of the following stock solution was filled in a transparent glass pressure vessel and an aluminum pressure vessel (both filled: 100 ml), and an aerosol valve was fixed. Then, 22 g (55% by mass) of liquefied gas (* 1) was filled from the aerosol valve, and 6 g (15% by mass) of dimethyl ether was further filled to produce an aerosol product. Said evaluation was performed about the obtained aerosol product. Table 7 shows the evaluation results. In addition, what used the undiluted | stock solution which extracted powder from the following undiluted | stock solution was evaluated as a reference | standard product.
<原液>
POE(20)POP(8)セチルエーテル(*2) 0.5
シリカ(*4) 0.5
ヒドロキシエチルセルロース(*3) 0.3
ジネオペンタン酸メチルペンタンジオール(*28) 3.0
N,N−ジメチルトルアミド 5.0
エタノール 10.0
精製水 80.7
合計(質量%) 100.0
<Undiluted solution>
POE (20) POP (8) Cetyl ether (* 2) 0.5
Silica (* 4) 0.5
Hydroxyethyl cellulose (* 3) 0.3
Dineopentanoic acid methylpentanediol (* 28) 3.0
N, N-dimethyltoluamide 5.0
Ethanol 10.0
Purified water 80.7
Total (mass%) 100.0
処方例9 日焼け防止剤<弾けるジェルタイプ>
下記の原液16g(40質量%)をポリエチレンテレフタレート製耐圧容器(満注量:100ml)に充填し、エアゾールバルブを固着した。そして、エアゾールバルブから液化ガス(*1)24g(60質量%)を充填してエアゾール製品を製造した。得られたエアゾール製品を用いて上記の評価を行った。評価結果を表7に示す。なお、下記原液からパウダーを抜いた原液を用いたものを基準品として評価した。
Formulation Example 9 Sunscreen Agent <Peeling Gel Type>
16 g (40% by mass) of the following stock solution was filled into a polyethylene terephthalate pressure vessel (full amount: 100 ml), and an aerosol valve was fixed. And aerosol product was manufactured by filling 24g (60 mass%) of liquefied gas (* 1) from the aerosol valve | bulb. Said evaluation was performed using the obtained aerosol product. Table 7 shows the evaluation results. In addition, what used the undiluted | stock solution which extracted powder from the following undiluted | stock solution was evaluated as a reference | standard product.
<原液>
POE−20ソルビタンココエート(*12) 1.0
シリカ(*4) 3.0
ヒドロキシエチルセルロース(*3) 0.5
メチルパラベン 0.1
シクロペンタシロキサン(*31) 3.0
メトキシケイヒ酸エチルヘキシル(*32) 6.0
ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル/
メトキシケイヒ酸エチルヘキシル(*33) 4.0
微粒子酸化チタン(*34) 2.0
微粒子酸化亜鉛(*35) 2.0
架橋ポリメタクリル酸メチル(*36) 0.5
l−メントール 0.1
ヒアルロン酸 0.1
エタノール 20.0
精製水 57.7
合計(質量部) 100.0
*31:SH 245(商品名)、東レ・ダウコーニング株式会社製
*32:パルソールMCX(商品名)、DSMニュートリションジャパン株式会社製
*33:Uvinul A plus B(商品名)、BASFジャパン株式会社製
*34:MT−100AQ(商品名)、テイカ株式会社製
*35:MZ−500HP(商品名)、テイカ株式会社製
*36:テクポリマーMBP−8(商品名)、積水化成品工業株式会社製
<Undiluted solution>
POE-20 sorbitan cocoate (* 12) 1.0
Silica (* 4) 3.0
Hydroxyethyl cellulose (* 3) 0.5
Methylparaben 0.1
Cyclopentasiloxane (* 31) 3.0
Ethylhexyl methoxycinnamate (* 32) 6.0
Diethylaminohydroxybenzoyl hexyl benzoate /
Ethylhexyl methoxycinnamate (* 33) 4.0
Fine particle titanium oxide (* 34) 2.0
Fine zinc oxide (* 35) 2.0
Cross-linked polymethyl methacrylate (* 36) 0.5
l-Menthol 0.1
Hyaluronic acid 0.1
Ethanol 20.0
Purified water 57.7
Total (parts by mass) 100.0
* 31: SH 245 (trade name), manufactured by Toray Dow Corning Co., Ltd. * 32: Pulsol MCX (trade name), manufactured by DSM Nutrition Japan Co., Ltd. * 33: Uvinul A plus B (trade name), manufactured by BASF Japan * 34: MT-100AQ (trade name), manufactured by Teika Corporation * 35: MZ-500HP (trade name), manufactured by Teika Corporation * 36: Techpolymer MBP-8 (trade name), manufactured by Sekisui Plastics Co., Ltd.
処方例10 消炎鎮痛剤<弾ける泡タイプ>
下記の原液16g(40質量%)をポリエチレンテレフタレート製の耐圧容器(満注量:100ml)に充填し、エアゾールバルブを固着した。そして、エアゾールバルブから液化ガス(*1)24g(60質量%)を充填してエアゾール製品を製造した。得られたエアゾール製品を用いて上記の評価を行った。評価結果を表7に示す。なお、下記原液からパウダーを抜いた原液を用いたものを基準品として評価した。
Formulation Example 10 Anti-inflammatory analgesic <Floating foam type>
16 g (40% by mass) of the following stock solution was filled into a polyethylene terephthalate pressure vessel (full amount: 100 ml), and an aerosol valve was fixed. And aerosol product was manufactured by filling 24g (60 mass%) of liquefied gas (* 1) from the aerosol valve | bulb. Said evaluation was performed using the obtained aerosol product. Table 7 shows the evaluation results. In addition, what used the undiluted | stock solution which extracted powder from the following undiluted | stock solution was evaluated as a reference | standard product.
<原液>
POE−20ソルビタンココエート(*12) 1.0
POE硬化ヒマシ油(*27) 1.0
POE(20)セチルエーテル(*20) 1.0
POE(2)ラウリルエーテル(*37) 1.0
シリカ(*4) 1.0
ヒドロキシエチルセルロース(*3) 0.2
メチルパラベン 0.1
l−メントール 2.0
サリチル酸メチル 4.0
香料 0.1
エタノール 15.0
精製水 73.6
合計(質量部) 100.0
*37:NIKKOL BL−2(商品名)、日光ケミカルズ株式会社製
<Undiluted solution>
POE-20 sorbitan cocoate (* 12) 1.0
POE hydrogenated castor oil (* 27) 1.0
POE (20) cetyl ether (* 20) 1.0
POE (2) Lauryl ether (* 37) 1.0
Silica (* 4) 1.0
Hydroxyethyl cellulose (* 3) 0.2
Methylparaben 0.1
l-Menthol 2.0
Methyl salicylate 4.0
Fragrance 0.1
Ethanol 15.0
Purified water 73.6
Total (parts by mass) 100.0
* 37: NIKKOL BL-2 (trade name), manufactured by Nikko Chemicals Co., Ltd.
処方例11 冷却剤<氷結タイプ>
下記の原液15g(30質量%)を透明なガラス製耐圧容器およびアルミニウム製耐圧容器(いずれも満注量:100ml)に充填し、エアゾールバルブを固着した。そして、エアゾールバルブから液化ガス(*1)17.5g(35質量%)を充填し、さらにハイドロフルオロオレフィン(*38)17.5g(35質量%)を充填しエアゾール製品を製造した。得られたエアゾール製品について上記の評価を行った。評価結果を表7に示す。なお、下記原液からパウダーを抜いた原液を用いたものを基準品として評価した。
Formulation Example 11 Coolant <Freeze Type>
15 g (30% by mass) of the following stock solution was filled in a transparent glass pressure vessel and an aluminum pressure vessel (both filled: 100 ml), and an aerosol valve was fixed. And 17.5 g (35 mass%) of liquefied gas (* 1) was filled from the aerosol valve | bulb, and also 17.5 g (35 mass%) of hydrofluoroolefin (* 38) was filled, and the aerosol product was manufactured. Said evaluation was performed about the obtained aerosol product. Table 7 shows the evaluation results. In addition, what used the undiluted | stock solution which extracted powder from the following undiluted | stock solution was evaluated as a reference | standard product.
<原液>
POE(20)POP(8)セチルエーテル(*2) 0.5
中空シリカビーズ(*4) 0.5
ヒドロキシエチルセルロース(*3) 0.1
メチルパラベン 0.1
エタノール 2.0
精製水 96.8
合計(質量%) 100.0
*38:トランス−1,3,3,3−テトラフルオロプロパ−1−エン(HFO−1234Ze(e))
<Undiluted solution>
POE (20) POP (8) Cetyl ether (* 2) 0.5
Hollow silica beads (* 4) 0.5
Hydroxyethyl cellulose (* 3) 0.1
Methylparaben 0.1
Ethanol 2.0
Purified water 96.8
Total (mass%) 100.0
* 38: trans-1,3,3,3-tetrafluoroprop-1-ene (HFO-1234Ze (e))
Claims (6)
水性原液と液化ガスとが乳化する乳化型エアゾール組成物であって、
前記パウダーが水性原液と液化ガスとが分離している状態では、
水性原液と液化ガスとの間に存在する乳化型エアゾール組成物。 Contains an aqueous stock solution containing surfactant and powder and liquefied gas,
An emulsified aerosol composition in which an aqueous stock solution and a liquefied gas are emulsified,
In the state where the aqueous stock solution and the liquefied gas are separated from the powder,
An emulsified aerosol composition present between an aqueous stock solution and a liquefied gas.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013240852A JP6282849B2 (en) | 2013-11-21 | 2013-11-21 | Emulsion type aerosol composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013240852A JP6282849B2 (en) | 2013-11-21 | 2013-11-21 | Emulsion type aerosol composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015101545A true JP2015101545A (en) | 2015-06-04 |
JP6282849B2 JP6282849B2 (en) | 2018-02-21 |
Family
ID=53377553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013240852A Active JP6282849B2 (en) | 2013-11-21 | 2013-11-21 | Emulsion type aerosol composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6282849B2 (en) |
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017088499A (en) * | 2015-11-02 | 2017-05-25 | ロレアル | Composition comprising thermoplastic hollow particles |
WO2018198301A1 (en) * | 2017-04-28 | 2018-11-01 | 東洋エアゾール工業株式会社 | Cracking aerosol composition |
JP2019026596A (en) * | 2017-07-31 | 2019-02-21 | 株式会社ダイゾー | Aerosol composition for quickly drying hair |
WO2019151004A1 (en) * | 2018-01-30 | 2019-08-08 | 株式会社 資生堂 | Cosmetic material for sunscreen |
JP2019131534A (en) * | 2018-01-30 | 2019-08-08 | 株式会社 資生堂 | Sunscreen cosmetic |
JP2020138953A (en) * | 2019-03-01 | 2020-09-03 | 株式会社ダイゾー | Foamable aerosol composition |
JP2020536947A (en) * | 2017-10-20 | 2020-12-17 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | Compact aerosol hair care composition containing hydrocarbon foaming agent |
JP2021024786A (en) * | 2019-07-31 | 2021-02-22 | 株式会社ダイゾー | Spray composition |
US11116705B2 (en) | 2017-10-10 | 2021-09-14 | The Procter And Gamble Company | Compact shampoo composition containing sulfate-free surfactants |
US11116704B2 (en) | 2017-10-10 | 2021-09-14 | The Procter And Gamble Company | Compact shampoo composition |
US11116703B2 (en) | 2017-10-10 | 2021-09-14 | The Procter And Gamble Company | Compact shampoo composition containing sulfate-free surfactants |
US11129775B2 (en) | 2017-10-10 | 2021-09-28 | The Procter And Gamble Company | Method of treating hair or skin with a personal care composition in a foam form |
US11129783B2 (en) | 2016-10-21 | 2021-09-28 | The Procter And Gamble Plaza | Stable compact shampoo products with low viscosity and viscosity reducing agent |
US11141370B2 (en) | 2017-06-06 | 2021-10-12 | The Procter And Gamble Company | Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel |
US11141361B2 (en) | 2016-10-21 | 2021-10-12 | The Procter And Gamble Plaza | Concentrated shampoo dosage of foam designating hair volume benefits |
US11154467B2 (en) | 2016-10-21 | 2021-10-26 | The Procter And Gamble Plaza | Concentrated shampoo dosage of foam designating hair conditioning benefits |
US11202740B2 (en) | 2016-10-21 | 2021-12-21 | The Procter And Gamble Company | Concentrated shampoo dosage of foam for providing hair care benefits |
US11224567B2 (en) | 2017-06-06 | 2022-01-18 | The Procter And Gamble Company | Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel |
US11291616B2 (en) | 2015-04-23 | 2022-04-05 | The Procter And Gamble Company | Delivery of surfactant soluble anti-dandruff agent |
US11318073B2 (en) | 2018-06-29 | 2022-05-03 | The Procter And Gamble Company | Low surfactant aerosol antidandruff composition |
US11446217B2 (en) | 2016-03-03 | 2022-09-20 | The Procter & Gamble Company | Aerosol antidandruff composition |
US11679073B2 (en) | 2017-06-06 | 2023-06-20 | The Procter & Gamble Company | Hair compositions providing improved in-use wet feel |
US11679065B2 (en) | 2020-02-27 | 2023-06-20 | The Procter & Gamble Company | Compositions with sulfur having enhanced efficacy and aesthetics |
US11771635B2 (en) | 2021-05-14 | 2023-10-03 | The Procter & Gamble Company | Shampoo composition |
US11819474B2 (en) | 2020-12-04 | 2023-11-21 | The Procter & Gamble Company | Hair care compositions comprising malodor reduction materials |
US11980679B2 (en) | 2019-12-06 | 2024-05-14 | The Procter & Gamble Company | Sulfate free composition with enhanced deposition of scalp active |
US11986543B2 (en) | 2021-06-01 | 2024-05-21 | The Procter & Gamble Company | Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants |
JP7536509B2 (en) | 2020-05-29 | 2024-08-20 | 株式会社 資生堂 | Aerosol cosmetics |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06271402A (en) * | 1993-03-17 | 1994-09-27 | Fumakilla Ltd | Vermin-repelling composition |
JPH11100308A (en) * | 1997-09-29 | 1999-04-13 | Pola Chem Ind Inc | Cosmetic making cracking sound |
JP2000063201A (en) * | 1998-08-12 | 2000-02-29 | Suzuki Yushi Kogyo Kk | Repellent composition in repellent for human body or repellent for animal and spray product and aerosol product using the same |
JP2002154925A (en) * | 2000-11-15 | 2002-05-28 | Sekisui Plastics Co Ltd | Spherical agglomerate for aerosol and aerosol agent containing the same |
JP2003055187A (en) * | 2001-08-20 | 2003-02-26 | Pola Chem Ind Inc | Foamlike massage cosmetic |
WO2004087078A1 (en) * | 2003-03-31 | 2004-10-14 | Shiseido Co., Ltd. | Cosmetic for cilia |
JP2006008547A (en) * | 2004-06-23 | 2006-01-12 | Shiseido Co Ltd | Multilayer type composition |
WO2014030754A1 (en) * | 2012-08-24 | 2014-02-27 | ロート製薬株式会社 | Composition for skin comprising hollow polymer particles |
-
2013
- 2013-11-21 JP JP2013240852A patent/JP6282849B2/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06271402A (en) * | 1993-03-17 | 1994-09-27 | Fumakilla Ltd | Vermin-repelling composition |
JPH11100308A (en) * | 1997-09-29 | 1999-04-13 | Pola Chem Ind Inc | Cosmetic making cracking sound |
JP2000063201A (en) * | 1998-08-12 | 2000-02-29 | Suzuki Yushi Kogyo Kk | Repellent composition in repellent for human body or repellent for animal and spray product and aerosol product using the same |
JP2002154925A (en) * | 2000-11-15 | 2002-05-28 | Sekisui Plastics Co Ltd | Spherical agglomerate for aerosol and aerosol agent containing the same |
JP2003055187A (en) * | 2001-08-20 | 2003-02-26 | Pola Chem Ind Inc | Foamlike massage cosmetic |
WO2004087078A1 (en) * | 2003-03-31 | 2004-10-14 | Shiseido Co., Ltd. | Cosmetic for cilia |
JP2006008547A (en) * | 2004-06-23 | 2006-01-12 | Shiseido Co Ltd | Multilayer type composition |
WO2014030754A1 (en) * | 2012-08-24 | 2014-02-27 | ロート製薬株式会社 | Composition for skin comprising hollow polymer particles |
Cited By (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11291616B2 (en) | 2015-04-23 | 2022-04-05 | The Procter And Gamble Company | Delivery of surfactant soluble anti-dandruff agent |
JP2017088499A (en) * | 2015-11-02 | 2017-05-25 | ロレアル | Composition comprising thermoplastic hollow particles |
US11446217B2 (en) | 2016-03-03 | 2022-09-20 | The Procter & Gamble Company | Aerosol antidandruff composition |
US11202740B2 (en) | 2016-10-21 | 2021-12-21 | The Procter And Gamble Company | Concentrated shampoo dosage of foam for providing hair care benefits |
US11154467B2 (en) | 2016-10-21 | 2021-10-26 | The Procter And Gamble Plaza | Concentrated shampoo dosage of foam designating hair conditioning benefits |
US11141361B2 (en) | 2016-10-21 | 2021-10-12 | The Procter And Gamble Plaza | Concentrated shampoo dosage of foam designating hair volume benefits |
US11129783B2 (en) | 2016-10-21 | 2021-09-28 | The Procter And Gamble Plaza | Stable compact shampoo products with low viscosity and viscosity reducing agent |
KR102277123B1 (en) * | 2017-04-28 | 2021-07-14 | 도요 에어로졸 고교 가부시키가이샤 | cracking aerosol composition |
JPWO2018198301A1 (en) * | 2017-04-28 | 2020-05-14 | 東洋エアゾール工業株式会社 | Cracking aerosol composition |
CN110520096A (en) * | 2017-04-28 | 2019-11-29 | 东洋喷雾工业株式会社 | Cracking aerosol composition |
US11007126B2 (en) * | 2017-04-28 | 2021-05-18 | Toyo Aerosol Industry Co., Ltd. | Cracking aerosol composition |
WO2018198301A1 (en) * | 2017-04-28 | 2018-11-01 | 東洋エアゾール工業株式会社 | Cracking aerosol composition |
KR20190109525A (en) * | 2017-04-28 | 2019-09-25 | 도요 에어로졸 고교 가부시키가이샤 | Cracking Aerosol Composition |
US11141370B2 (en) | 2017-06-06 | 2021-10-12 | The Procter And Gamble Company | Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel |
US11224567B2 (en) | 2017-06-06 | 2022-01-18 | The Procter And Gamble Company | Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel |
US11679073B2 (en) | 2017-06-06 | 2023-06-20 | The Procter & Gamble Company | Hair compositions providing improved in-use wet feel |
JP7078362B2 (en) | 2017-07-31 | 2022-05-31 | 株式会社ダイゾー | Aerosol composition for quick-drying hair |
JP2019026596A (en) * | 2017-07-31 | 2019-02-21 | 株式会社ダイゾー | Aerosol composition for quickly drying hair |
US11129775B2 (en) | 2017-10-10 | 2021-09-28 | The Procter And Gamble Company | Method of treating hair or skin with a personal care composition in a foam form |
US11904036B2 (en) | 2017-10-10 | 2024-02-20 | The Procter & Gamble Company | Sulfate free clear personal cleansing composition comprising low inorganic salt |
US11992540B2 (en) | 2017-10-10 | 2024-05-28 | The Procter & Gamble Company | Sulfate free personal cleansing composition comprising low inorganic salt |
US11116703B2 (en) | 2017-10-10 | 2021-09-14 | The Procter And Gamble Company | Compact shampoo composition containing sulfate-free surfactants |
US11116704B2 (en) | 2017-10-10 | 2021-09-14 | The Procter And Gamble Company | Compact shampoo composition |
US11116705B2 (en) | 2017-10-10 | 2021-09-14 | The Procter And Gamble Company | Compact shampoo composition containing sulfate-free surfactants |
JP2020536947A (en) * | 2017-10-20 | 2020-12-17 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | Compact aerosol hair care composition containing hydrocarbon foaming agent |
JP2019131534A (en) * | 2018-01-30 | 2019-08-08 | 株式会社 資生堂 | Sunscreen cosmetic |
WO2019151004A1 (en) * | 2018-01-30 | 2019-08-08 | 株式会社 資生堂 | Cosmetic material for sunscreen |
JP7188945B2 (en) | 2018-01-30 | 2022-12-13 | 株式会社 資生堂 | sunscreen cosmetics |
US11318073B2 (en) | 2018-06-29 | 2022-05-03 | The Procter And Gamble Company | Low surfactant aerosol antidandruff composition |
JP2020138953A (en) * | 2019-03-01 | 2020-09-03 | 株式会社ダイゾー | Foamable aerosol composition |
JP7325973B2 (en) | 2019-03-01 | 2023-08-15 | 株式会社ダイゾー | Effervescent aerosol composition |
JP7396828B2 (en) | 2019-07-31 | 2023-12-12 | 株式会社ダイゾー | Composition for spraying |
JP2021024786A (en) * | 2019-07-31 | 2021-02-22 | 株式会社ダイゾー | Spray composition |
US11980679B2 (en) | 2019-12-06 | 2024-05-14 | The Procter & Gamble Company | Sulfate free composition with enhanced deposition of scalp active |
US11679065B2 (en) | 2020-02-27 | 2023-06-20 | The Procter & Gamble Company | Compositions with sulfur having enhanced efficacy and aesthetics |
JP7536509B2 (en) | 2020-05-29 | 2024-08-20 | 株式会社 資生堂 | Aerosol cosmetics |
US11819474B2 (en) | 2020-12-04 | 2023-11-21 | The Procter & Gamble Company | Hair care compositions comprising malodor reduction materials |
US11771635B2 (en) | 2021-05-14 | 2023-10-03 | The Procter & Gamble Company | Shampoo composition |
US11986543B2 (en) | 2021-06-01 | 2024-05-21 | The Procter & Gamble Company | Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants |
Also Published As
Publication number | Publication date |
---|---|
JP6282849B2 (en) | 2018-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6282849B2 (en) | Emulsion type aerosol composition | |
ES2227563T3 (en) | SPRAY COMPOSITIONS CONTAINING DISPERSED POWDER AND PROCEDURES TO USE THE SAME. | |
ES2759206T3 (en) | Capsule containing fragrance and cosmetic product in which said capsules are mixed | |
WO2019126442A1 (en) | Low viscosity conditioner composition containing silicone polymers | |
EP2614815B1 (en) | Foamable aerosol composition | |
KR101500991B1 (en) | Personal care composition containing a volatile and a terpene alcohol | |
JP2004513958A (en) | Cosmetic or dermatological agent in the form of a creamy permanent foam or a stable foam cream | |
JP5981161B2 (en) | Hairdressing composition | |
JP5781783B2 (en) | Aerosol composition | |
BR112018073118B1 (en) | FOAMING FORMULATION, METHOD FOR PREPARING A FOAMABLE FORMULATION, AND PRESSURIZED PACKAGING | |
JP6157969B2 (en) | Aerosol-type foamy sunscreen | |
JP2019094273A (en) | Aerosol foamy sunscreen cosmetic | |
JP2010006738A (en) | Foamable aerosol composition | |
JP4098093B2 (en) | Aerosol products | |
JP5180601B2 (en) | Aerosol composition | |
JP2009249343A (en) | Aerosol composition | |
JP2010270060A (en) | Aerosol composition | |
JP6448923B2 (en) | Fixed-quantity aerosol products | |
JP2013112798A (en) | Emulsion aerosol composition | |
JP2003313101A (en) | Aerosol composition and aerosol product | |
JP6985411B2 (en) | Cracking aerosol composition | |
JP5920777B2 (en) | Foamable aerosol composition | |
JP2002275454A (en) | Water-containing aerosol composition and method for stabilizing water-containing aerosol product | |
JP3198460B2 (en) | Powder aerosol composition | |
US11007126B2 (en) | Cracking aerosol composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160829 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20160829 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20170622 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170704 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170830 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180123 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20180125 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6282849 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |